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Abstract 
Tumour motion presents a significant limitation for effective radiotherapy of lung cancer, 
and more specifically for helical tomotherapy.  The simultaneous and continuous movements 
of tomotherapy subsystems (gantry, couch, and binary multi-leaf collimator) can lead to 
inaccurate dose delivery, when combined with tumour motion.  In this thesis, we have 
investigated the impact of tumour motion and strategies to reduce the resulting dose 
discrepancies for helical tomotherapy, through computer simulations and film measurements 
performed in a dynamic body phantom.  Three distinctively different types of dose 
discrepancies have been isolated: dose rounding, dose rippling, and the intensity-modulated 
radiation therapy (IMRT) asynchronization effect.  Each effect was shown to be affected by 
different combinations of tumour motion and treatment parameters.  In clinical practice using 
a conventional fractionation scheme, the dose rounding effect remains the major concern, 
which can be compensated by assigning a larger treatment margin around the tumour volume.  
For hypofractionation schemes, the IMRT asynchronization effect can become an additional 
concern by introducing dose discrepancies inside the target volume, necessitating the use of a 
motion management technique.   
Two new motion management techniques have thus been developed for helical tomotherapy: 
loose helical tomotherapy with breath-holding and multi-pass respiratory gating.  Both 
methods require the treatment couch to be reset to its starting position to repeat the entire 
helical treatment, until nearly all planned dose is delivered.  For sinusoidal target motion, 
employing multi-pass respiratory gating was shown to reduce the dose deviation inside the 
target volume from 14% to 2% for a single fraction, using 4 gated passes.  For non-sinusoidal 
tumour motion causing a dose deviation of 6% within the tumour volume, the required 
number of passes to keep the dose deviation below 1% was approximately 4 passes for 30 
fractions and 5 passes for 3 fractions, demonstrating the feasibility of the multi-pass 
respiratory gating approach.  Clinical implementation of the multi-pass respiratory gating 
technique would require a number of electronic control and communication modifications to 
the existing tomotherapy machine, which would lead to significant improvements in the dose 
distributions delivered for lung tomotherapy treatments – especially for patients exhibiting 
large tumour motion who are treated with hypofractionation schemes. 
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Chapter 1  
1 Introduction 
This chapter provides a background overview of the research work presented in this 
thesis dissertation, as well as the research objectives, hypothesis, scope, and the roadmap 
of this thesis work. 
1.1 General Overview 
In 2009, there were an estimated 171,000 new cancer cases and 75,300 cancer-related 
deaths in Canada.  Lung cancer accounted for 14% of all cancer incidences, but caused 
27% of all cancer deaths, making it the leading cause of cancer deaths in Canada.  The 5-
year overall survival rate for lung cancer has been historically very low at 15%, 
compared to the average value of 62% for all cancer sites [1].  There is a clear need to 
improve the treatment of this disease.   
Three different approaches routinely used for treating cancer are surgery, radiotherapy, 
and chemotherapy.  For non-small cell lung cancer (NSCLC), these treatment methods 
may be used individually, or in combinations.  Surgery has shown to yield highly 
successful clinical outcomes, with 5-year overall survival rates in the range of 50-70% 
[2,3].  However, surgery is suitable for only one-third of all patients, who are mostly in 
the early stages of the disease.  The inoperable NSCLC patients may be treated with 
radiotherapy alone, or in combination with chemotherapy.  For medically inoperable 
NSCLC, early stage patients account for 10-15%, while locally advanced cases make up 
for 30-40% of the patient population [4].1  When radiotherapy with conventional dose 
prescription is used alone, the 5-year overall survival rates are in the range of 6-32% for 
the early stage cases, while generally not exceeding 5% for the locally advanced cases 
[5,6].  Although different treatment schemes may be employed to improve the 
                                                 
1
 The remaining 12-27% of NSCLC patients account for more advanced cases. 
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effectiveness of traditional radiotherapy, the resulting clinical outcomes still remain far 
inferior to those achievable with surgery [2-5]. 
Recently, stereotactic body radiotherapy (SBRT) has emerged as a promising technique 
to improve clinical outcomes for early-stage NSCLC, achieving results comparable to 
surgery through intensified dose regimens [7-14].  There have been a number of clinical 
studies in North America, Europe, and Asia, investigating the effectiveness of stereotactic 
body radiotherapy (SBRT), employing a very small number of dose fractions 
(hypofractionation) for treating NSCLC.  From the currently on-going clinical trial 
(RTOG 2306), 2-year and 3-year overall survival rates of 54.7% and 42.7% have been 
reported, respectively [9,10].  In a different study, 5-year overall survival rates as high as 
72% and 83% have been observed [11], while 3-year overall survival rates of 47-60% 
were reported in several multi-institutional studies [12-14].  However, there are 
remaining concerns for normal tissue complications in the areas of skin, chest wall and 
rib, due to the high dose given during each fraction [15].  Thus, more long-term data will 
be required to determine whether SBRT can be adopted as the new standard radiotherapy 
practice for early stage NSCLC.  
Local recurrence is the major reason for high failure rates of lung cancer radiotherapy [7].  
Local relapse rates of 6 to 70%, with a median of 40%, have been reported from various 
studies [16,17].  The major contributing factor for high local recurrences is the 
insufficient dose given to the tumour volume, limited by the dose tolerance of 
surrounding organs at risk (OAR), such as normal lungs, heart, and spinal cord.  
Radiosensitivity of surrounding lung tissues places a limit on the maximum dose 
deliverable to the tumour volume, so that radiation-induced complications, such as 
radiation pneumonitis and radiation fibrosis, can be avoided [18].  The effort to spare 
lung tissues, however, comes at the expense of local tumour control.  Local tumour 
control has been shown to improve with dose escalation [2,4,5,12].  The presence of 
tumour motion driven by patient breathing [19-22] further limits the maximum dose 
deliverable to the tumour volume, as an additional margin is generally assigned around 
the tumour volume to encompass the entire range of tumour motion.  This significantly 
increases the total irradiated volume of normal lung tissues [20].  In addition, the 
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presence of tumour motion during dose delivery can generate unwanted dose 
discrepancies inside the tumour volume [20].   
Thus, for lung radiotherapy, the use of a highly conformal dose delivery technique 
becomes essential for improving normal tissue sparing, while simultaneously enabling 
dose escalation.  In the presence of tumour motion, it is crucial to minimize the required 
margin size and the magnitude of motion-induced dose discrepancies, by employing an 
effective motion-management method for the chosen dose delivery technique.  In this 
dissertation, helical tomotherapy was selected as the dose delivery technique for lung 
cancer, due to its highly conformal dose delivery capability.  Motion management for 
helical tomotherapy becomes the focal point of this thesis, as motion management is 
currently not available clinically for helical tomotherapy.  In this work, we have 
identified and systematically categorized the different types of motion-induced dose 
discrepancies for helical tomotherapy, while investigating their characteristics in relation 
to different treatment and respiratory parameters.  Feasibility of breath-holding and 
respiratory gating techniques for helical tomotherapy was then investigated, in terms of 
their effectiveness for reducing the magnitude of the different motion-induced dose 
discrepancies. 
1.2 Radiation Therapy Techniques 
The goal of radiation therapy is to concentrate the dose of radiation to the tumour volume, 
while minimizing the dose to surrounding normal structures.  During the course of a 
radiation treatment, the prescription dose is usually divided up and delivered in multiple 
fractions, over a period of weeks, rather than completed in its entirety in a single fraction.  
The purpose of dose fractionation is to preserve the normal tissues, while allowing cell 
cycle redistribution and reoxygenation of the tumour cells for more effective tumour cell 
killings [23].  For conventional lung radiotherapy, a prescription dose of 60 Gy is 
typically delivered over 30 fractions with 2 Gy given per fraction. 
For radiotherapy, a linear accelerator (Figure 1.1) is conventionally used to deliver 
radiation dose distribution conformal to the target volume.  A patient is placed on the 
treatment couch, while a mega-voltage x-ray beam is generated and emitted from the 
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gantry head.  The gantry can be rotated to treat the tumour volume from various angles.  
In Figure 1.2, the radiation is shown to be delivered to the lung tumour volume, outlined 
by the yellow contour, using four treatment beams from different gantry angles.  In the 
resulting dose distribution shown in percentage of the prescription dose, the tumour 
volume is being covered by the high dose region shown in red (95%), while the other 
normal structures such as lungs, heart, and spinal cord are located in the low dose regions, 
depicted in cyan (40%) and blue (20%). Various radiation delivery techniques have been 
proposed and used over the years, in an effort to improve dose conformity and normal 
tissue sparing.  The different techniques will be described in the order of complexity in 
following sections. 
 
Figure 1.1: Photograph of a Varian Clinac iX linear accelerator (Varian Medical 
Systems, Palo Alto, CA) at London Regional Cancer Program. 
5 
 
 
Figure 1.2: Dose distribution of a 4-beam plan for a lung lesion (yellow).  The red 
colour represents high dose region receiving more than 95% of the prescription dose, 
while the low dose regions are depicted with cyan (40%) and blue (20%).  The ‘red’ 
beam profiles depict the unique fluence patterns (i.e. intensity modulation) for each 
of the treatment beams. 
1.2.1 Three-Dimensional Conformal Radiation Therapy (3D-CRT) 
Three-dimensional conformal radiation therapy (3D-CRT) is performed by shaping each 
treatment beam according to the projected target shape at a given gantry angle [24].  The 
beam aperture can be modified with shielding blocks, or by utilizing a multi-leaf 
collimator (MLC) [25,26].  An example of a MLC system is shown in Figure 1.3, which 
consists of 120 collimator leaves for shaping a radiation field and/or generating intensity 
modulation within the field.   
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Figure 1.3: Varian 120 leaf Millennium multi-leaf collimator (MLC) (Courtesy of 
Varian Medical Systems, Palo Alto, CA, Image from www.varian.com). 
1.2.2 Fixed Gantry Intensity Modulated Radiation Therapy (IMRT) 
Intensity modulated radiation therapy (IMRT) is an advanced form of 3D-CRT that 
utilizes conformal radiation fields with non-uniform fluence, with an intent to deliver 
uniform dose to the tumour volume [27].  The built-in MLC system of the conventional 
linear accelerator allows for an IMRT delivery to be carried out either in a “step-and-
shoot” or “sliding window” mode [28].  In the “step-and-shoot” approach, a sequence of 
static segments shaped by the MLC leaves is delivered at a fixed gantry angle, while in 
the “sliding window” mode, also known as the “dynamic MLC” approach, the MLC 
leaves move continuously during irradiation at a fixed gantry angle.   
The dose conformity and normal tissue sparing can be further improved by increasing the 
number of fixed gantry angles, from which radiation is delivered.  In Figure 1.3, a 
conformal dose distribution is generated by assigning each of the four treatment beams 
with unique and non-uniform fluence patterns represented by the ‘red’ beam profiles.  An 
additional degree of freedom may be introduced by using the couch angle for non-
coplanar treatments [29]. 
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1.2.3 Rotation Therapy 
The benefits of using multiple beams to improve dose conformity can be fully exploited 
by employing continuous gantry rotation during radiation delivery.  The treatment may 
consist of a single or multiple arcs, where each individual arc may cover up to a full 3600 
rotation [30-36].  Traditional rotation therapy used a fixed beam aperture shaped 
according to the target volume for the entire dose delivery [30].  In a specialized case 
with a fixed beam aperture, both gantry and couch rotations may occur simultaneously, as 
in dynamic stereotactic radiosurgery (DSR) [37,38].   
For conformal arc therapy, rotational dose delivery is made with a dynamic MLC to 
adapt the beam aperture according to the projected target shape at each gantry angle [31].  
Intensity modulated arc therapy (IMAT) utilizes a dynamic MLC to deliver a single level 
of fluence to the target volume during each individual arc [32-34].  Thus, multiple arcs 
are normally required to generate more complex fluence patterns for IMAT.  Volumetric 
modulated arc therapy (VMAT) is capable of achieving the planned dose distribution in a 
single rotation, by introducing additional degrees of freedom of varying the gantry 
rotation speed and dose rate [35,36].  The currently available commercial systems 
employing the VMAT technique include Varian RapidArc (Varian Medical Systems, 
Palo Alto, CA), and Philips SmartArc (Philips Healthcare, Andover, MA).  Varian 
Medical Systems has recently upgraded their RapidArc system to allow for the delivery 
of multiple arcs to generate even more sophisticated fluence patterns for radiation therapy.    
1.2.4 Tomotherapy 
In contrast to the use of a cone beam of radiation that covers the entire target volume, the 
target volume may also be treated in slices by utilizing a fan beam of radiation.  Such 
delivery techniques can further improve the capability of producing more sophisticated 
in-plane fluence patterns, but at the expense of prolonged treatment time.   
1.2.4.1 Serial Tomotherapy 
For serial tomotherapy, each slice within the target volume is treated with a full or partial 
gantry rotation.  After completing the dose delivery to each target slice, the treatment 
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couch is indexed to the next target slice position for irradiation [39].  The fluence within 
the fan beam is modulated by two rows of 64 binary MLC (b-MLC) leaves that either 
move in or out of the fan beam field.  Intensity modulation is achieved by varying the 
duration of each leaf opening as a function of beam projection.  However, the treatment 
couch indexing between target slices introduces couch positional uncertainty, which can 
lead to unwanted “hot or cold” dose spots at the junctions of slices.  This problem can be 
resolved by employing a continuous couch motion that occurs simultaneously with the 
gantry rotation, as in the case for helical tomotherapy. 
1.2.4.2 Helical Tomotherapy 
Helical tomotherapy combines continuous gantry rotation and linear couch motion to 
deliver a 6 MV x-ray fan beam to the target volume in a helical manner [40-42].  A Hi-
Art II helical tomotherapy unit (TomoTherapy Inc., Madison, WI) is currently being used 
clinically at London Regional Cancer Program (Figure 1.4 a).  The fan beam has a 
projected width (X) of 40 cm at the isocenter (SAD = 85 cm), which is further divided 
into 64 beamlets by a single row of binary multi-leaf collimator (b-MLC) leaves (Figure 
1.4 b).  There are three different available fan beam thickness (b) of 1.05 cm, 2.5 cm, and 
5.0 cm projected at the isocenter along the longitudinal direction (Y). 
Other helical tomotherapy parameters include pitch factor, and gantry rotation period.  
Pitch factor (p) is defined as the longitudinal (Y) distance advanced by the treatment 
couch per gantry rotation, in units of fan beam thickness (b).  Gantry rotation period (Tg) 
is the time required to complete one full 3600 rotation.  Gantry rotation periods of less 
than 20 s are typically used clinically for lung tomotherapy.  For dose calculation 
purposes, each gantry rotation is virtually divided into 51 equally-spaced beam 
projections (each spanning ~70), during which the individual b-MLC leaves either travel 
into and out of the fan beam field.  Intensity modulation is achieved by varying the 
durations of individual leaf openings for each beam projection. 
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Figure 1.4: Photographs of a) Hi-Art II helical tomotherapy machine 
(TomoTherapy, Inc., Madison, WI) at London Regional Cancer Program, and b) 
binary multi-leaf collimator (b-MLC). 
The helical tomotherapy unit was the first radiotherapy machine to incorporate an on-line 
CT imaging capability for patient set-up verification at the start of each treatment fraction.  
The mega-voltage CT (MVCT) images of a patient acquired with the downshifted energy 
of 3.5 MV are compared to the planning kilo-voltage (kV) CT images to ensure that the 
patient is appropriately positioned [43,44]. 
1.3 Image Guidance Techniques 
Historically, for radiotherapy, the patient position used during the treatment planning 
process was replicated mainly with the help of skin tattoos at the start of each treatment 
fraction [45,46].  However, the internal anatomy can change in relation to the patient 
surface, between the time of CT imaging for treatment planning and the start of a 
treatment fraction [47,48].  Thus, relying solely on the skin tattoos for patient set-up is 
insufficient, due to the tumour position uncertainty arising from the interfraction variation 
of patient anatomy.  Although the dosimetric errors caused by the interfraction variation 
of tumour position may average out over multiple fractions with the use of a proper 
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margin [49-51], the use of image guidance to directly verify tumour position at the start 
of each treatment fraction becomes essential in accurately delivering the planned dose 
distribution to the tumour volume.  This will allow for a possible margin reduction to 
lower radiation toxicity, as well as dose escalation for an increased local tumour control 
[52,53].   In some instances, it also becomes necessary to track the tumour position in 
real-time to account for the intrafraction variation of the tumour position.  In this section, 
the different methods to monitor the interfraction and intrafraction variation of tumour 
position will be described.   
1.3.1 Two-Dimensional (2D) Mega-Voltage (MV) Imaging 
Using the mega-voltage (MV) x-ray treatment beam, two-dimensional projection images 
of the patient can be acquired with film or digitally with an electronic portal imaging 
device (EPID) [54-56].  The resulting projection images can then be aligned with the 
digitally reconstructed radiographs (DRR) generated from the planning CT datasets [57].  
During the comparison process, positions of visible bony landmarks relative to the 
radiation field edge are used to verify the tumour position indirectly [58,59].  However, 
possibilities still exist for the tumour position to change with respect to the bony 
structures [19].  Direct verification of the tumour position can be achieved with the use of 
fiducial markers implanted into the tumour volume at the risk of potential surgical 
complications, such as pneumothorax [46,47].  Although various technologies have been 
available for electronic portal imaging, the majority of the currently available systems 
utilize amorphous silicon flat panel imagers (FPI) [54].  The commercial FPI-based 
systems include Varian PortalVision (Varian Medical Systems, Palo Alto, CA) and 
Elekta iViewGT (Elekta Oncology, Stockholm, Sweden).  
1.3.2 Two-Dimensional (2D) kilo-Voltage (kV) Imaging 
Projection images exhibiting better contrast can be generated with the use of kilo-voltage 
(kV) x-ray sources in the treatment room.  However, direct verification of tumour 
position may still require the use of fiducial markers implanted into the tumour volume 
[58,59].  Multiple x-ray tubes may be used, so that the orthogonal projection images 
produced by the corresponding detectors can be combined to provide some 3D 
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information [54].  In the commercially available robotic radiosurgery systems [60,61], 
such as BrainLAB Novalis (BrainLAB AG, Feldkirchen, Germany) and Accuray 
Cyberknife (Accuray, Sunnyvale, CA), two x-ray tubes are mounted on the ceiling, while 
the flat panel imagers are located in the floor.  Conversely, the system developed by the 
Shirato group utilizes four floor-mounted x-ray tubes and x-ray image intensifiers 
installed on the ceiling [62-64]. 
1.3.3 Three-Dimensional (3D) kilo-Voltage (kV) CT Imaging 
Direct 3D imaging of soft tissues can be achieved by performing CT imaging inside the 
treatment room.  In the “CT-on-rails” approach, a separate CT scanner is installed inside 
the treatment room, such that the treatment couch can be shared between the treatment 
unit and the CT scanner [65,66].  The commercial systems include Varian ExaCT (Varian 
Medical Systems, Palo Alto, CA), and Siemens Primatom (Siemens AG, Erlangen, 
Germany).   
The existing linear accelerator can also be modified to incorporate cone beam CT 
(CBCT) imaging, where an additional kV x-ray tube is mounted orthogonal to the gantry 
head to rotate with the gantry, sharing the same axis of rotation [67-71].  By employing a 
cone beam geometry that covers the entire region of interest within the patient, a 3D CT 
image can be acquired in a single rotation.  However, the increased scattered x-rays 
generated due to the large field size must be accounted for to obtain better quality and 
quantifiable CT number data for dose computations.  The commercial linear accelerators 
equipped with the CBCT system include Elekta Synergy (Elekta Oncology, Stockholm, 
Sweden), Varian On-Board Imager (OBI) (Varian Medical Systems, Palo Alto, CA), and 
Siemens Artiste (Siemens AG, Erlangen, Germany).  These commercial systems also 
provide electronic portal and kV-fluoroscopic imaging capabilities.  Alternatively, the 
linear accelerator can also be designed to generate both kV and MV x-ray beams from the 
same source position.  In the Siemens Artiste system (Siemens AG, Erlangen, Germany), 
the kV beam is generated by utilizing a carbon target instead of tungsten target, while 
retracting the beam flattening filter.   
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1.3.4 Three-Dimensional (3D) Mega-Voltage (MV) CT Imaging 
Cone Beam CT (CBCT) imaging can also be performed with the treatment MV x-rays, 
requiring fewer modifications to the existing linear accelerator design [72-76].  An 
example of such system is Siemens MVision (Siemens AG, Erlangen, Germany).  As 
noted previously, helical tomotherapy is capable of providing MVCT imaging, using a 
fan beam similar to that of the diagnostic CT units.  With a gantry rotation period of 10 s 
[39], the current TomoTherapy Hi-Art II system (TomoTherapy Inc., Madison, WI) 
offers three different MVCT acquisition modes with slice spacing of 6 mm (coarse), 4 
mm (normal), and 2 mm (fine) [77-79]. 
1.3.5 Real-Time Tumour Tracking Methods 
The 2D-kV imaging system described in Section 1.3.2 can be used to directly monitor the 
tumour position in real-time.  Projection images are acquired periodically during the 
treatment to track the fiducial markers implanted into the tumour volume [60-64].  
However, this approach is not applicable for helical tomotherapy, due to the ring gantry 
configuration of the tomotherapy machine restricting the access of the fluoroscopic tubes.  
Direct monitoring of the tumour volume can also be carried out without the use of 
radiation.  With the Calypso system (Calypso Medical Technologies, Inc., Seattle, WA), 
electromagnetic transponders implanted into the tumour volume are tracked 
electromagnetically by the localization array panel mounted onto the treatment couch 
[80,81].  The relatively compact size of the localization array panel also makes the use of 
the Calypso system feasible for all radiotherapy machines, including helical tomotherapy. 
The tumour volume can also be monitored indirectly in real-time by tracking a tumour 
surrogate that represents the tumour position.  The examples of tumour surrogates include 
chest or abdominal motion, lung volume and/or speed of air flow measured by spirometry 
[82,83], or pressure measured by an abdominal strain gauge [84].  In the Real-time 
Position Management (RPM) system (Varian Medical Systems, Palo Alto, CA), the 
movement of an infrared reflective plastic box placed on patient’s chest or abdomen is 
monitored by an in-room camera.  A commercial example of an abdominal strain gauge 
is the fixation belt used for the AZ-733V respiratory gating system (Anzai Medical Co., 
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Ltd, Tokyo, Japan), that is wrapped around the patient abdomen.  The resulting 
abdominal pressure changes are then measured with a pressure sensor attached to the 
fixation belt.  Although indirect monitoring removes the surgical complication risks of 
implanting fiducial markers, an accurate correlation must be established between the 
actual tumour position and the tumour surrogate.  In addition, one must ensure that the 
same correlation is being maintained throughout the course of treatment.  The internal-
external correlation between the tumour position and tumour surrogate may be verified 
with the use of 4D-CT imaging [85-89]. 
1.3.6 Future Outlook 
Currently, both the CBCT and MV imaging techniques are being used only for geometric 
verification of the tumour position.  The next step would be to perform dose calculations 
using the acquired CT data, to determine whether the planned dose distribution is being 
delivered to the tumour volume, and if the existing plan needs to be re-optimized during 
the course of treatment.  However, the CT numbers generated by these imaging 
modalities are not yet reliable enough for dosimetric adaptations [90-96].  With the use of 
four-dimensional (4D) CT imaging [85-89] becoming more prevalent for treatment 
planning, employing a four-dimensional (4D) image guidance technique may become a 
clinical practice of the future.  Direct comparisons could then be made between the 
planning 4D-CT and 4D-CBCT images generated at the same phase of the respiratory 
cycle [97].  A MRI system may also be incorporated into the linear accelerator to provide 
superior soft tissue contrast, while avoiding the need for giving additional radiation dose 
to the patient.  However, significant technological hurdles still remain, such as the 
interference between the electromagnetic fields of the linear accelerator and the MRI 
system [98,99].   
1.4 Tumour Motion and Motion-Induced Dose 
Discrepancies 
Tumour motion resulting from patient breathing is a significant problem for lung 
radiotherapy.  It forces the clinicians to use a larger margin around the tumour volume, in 
an effort to encompass the full extent of tumour motion.  As a result, a significant volume 
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of surrounding normal lung tissues is irradiated, increasing radiation toxicities and 
placing a limit on the maximum dose that can be prescribed to the tumour volume.  In 
addition, the presence of tumour motion during dose delivery can produce dose 
discrepancies between the planned and delivered dose distributions to the tumour volume, 
affecting the accuracy of dose delivery.  These major issues caused by tumour motion can 
compromise the clinical benefits of radiotherapy and lead to suboptimal local tumour 
control of lung cancer.  In this section, the mechanics of breathing and extent of lung 
tumour motion will be described, as well as the impact of tumour motion for different 
radiation treatment modalities, including helical tomotherapy. 
1.4.1 Mechanics of Breathing 
Breathing is a physiological process alternating between inspiration and expiration to 
facilitate gas exchanges between blood and air inside the lungs.  Lungs are located within 
the thoracic cavity, surrounded by a fluid-filled pleural cavity.  The inner membrane of 
the pleural cavity envelops the lungs, while its outer membrane is attached to the thoracic 
wall, holding the lungs in place.  Due to this unique anatomical arrangement, volume of 
the thoracic cavity directly affects the pressure inside the pleural cavity (intrapleural 
pressure) and the lungs (alveolar pressure).  During breathing, the alveolar pressure varies 
from being slightly below or above the atmospheric pressure, causing the air to either 
flow in or out of the lungs.  On the other hand, the intrapleural pressure always remains 
far below the atmospheric pressure to keep the lungs from collapsing [20]. 
During inhalation, the expansion of the thoracic cavity occurs in all dimensions, driven 
by the active contractions of the diaphragm and the intercostal muscles connecting the 
ribs.  The superior-inferior (SI) dimension of the thoracic cavity is expanded with the 
diaphragm descending inferiorly, while the contracting intercostal muscles pull the ribs 
superiorly and anteriorly to increase the anterior-posterior (AP) and lateral diameters of 
the thoracic cavity.  The thoracic cavity expansion is then accompanied by a volumetric 
increase of the pleural cavity, and a simultaneous decrease in intrapleural pressure.  Due 
to the decrease of pressure just outside the lungs, the lungs also undergo volumetric 
expansions, causing the alveolar pressure inside the lungs to drop below the atmospheric 
pressure.  Thus, air is drawn into the lungs, until the alveolar pressure reaches the 
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atmospheric pressure.  During the exhalation, both diaphragm and intercostal muscles 
passively return to their pre-inhalation states, restoring the previous lung volume and 
pressure, pushing air out of the lungs.  The complex elastic property of the lung also 
contributes to its volume-pressure relationship exhibiting hysteresis, where the inhalation 
lung volume is always smaller than the exhalation lung volume at the same 
transpulmonary pressure, i.e. the difference between the alveolar pressure and 
intrapleural pressure [100].  In relations to dose computations and dose delivery, the lung 
is a complex dose absorber due to its variable shape and density. 
1.4.2 Measurements of Tumour Motion 
Various studies have employed different imaging modalities, such as fluoroscopy, CT 
and MRI to investigate tumour motion at different locations with the lung (upper, middle 
and lower lung) [19,20].  Fluoroscopy techniques included film radiography, MV portal 
imaging, and kV fluoroscopy, with and without the use of fiducial markers.  Parameters 
of lung tumour motion, such as magnitude, period, regularity, and baseline variation were 
shown to vary widely between individual patients.  Although it was difficult to establish a 
strong correlation between tumour displacement and tumour location within the lung, the 
greatest 3D tumour displacements were observed for the lower lung tumours, due to the 
influence of diaphragmatic motion.  Mean displacements of up to 18.5 mm, 7 mm, and 
12.6 mm were reported in the superior-inferior (SI), anterior-posterior (AP), and left-right 
(LR) direction, respectively [19-21].  Thus, proximity of the tumour position to the 
diaphragm may serve as a strong indicator for the presence of predominant SI tumour 
motion.  In some studies, the diaphragm position was used as the tumour surrogate for 
monitoring, due to the difficulty of viewing the actual tumour volume [101-104].  For 
lower and middle lung tumours, the displacements of up to 38.7 mm and 26.1 mm were 
observed in the SI direction [21].  However, the largest tumour displacement was 
reported for an upper lung tumour, which exhibited a displacement of up to 50 mm in the 
SI direction [19]. 
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1.4.3 Motion-Induced Dose Discrepancies for Helical Tomotherapy 
The presence of tumour motion during dose delivery can lead to significant dose 
discrepancies between the planned and delivered dose distributions.  This motion-induced 
dosimetric problem may not be simply resolved by assigning a larger margin around the 
tumour volume, as the dose distribution within the tumour volume and surrounding 
region is being affected.  Thus, it becomes crucial to understand the relationships 
between the treatment and tumour motion parameters, and discover ways to minimize the 
magnitude of overall dose discrepancies. 
Motion-induced dose discrepancies have been reported in the literature for different 
IMRT techniques.  The interplay between the MLC motion and tumour motion prevent 
the intended dose distribution from being delivered to the tumour volume, as the interplay 
effect is not modelled during treatment planning [49,50,105,106].  The problem becomes 
even more complicated for helical tomotherapy, which employs three simultaneously 
moving subsystems (gantry, couch, and b-MLC).  As a result, possibilities for a greater 
number of interplay and interactions with tumour motion can exist.  The impact of 
tumour motion during helical tomotherapy has been studied [49,107-109].  Gradual 
changes in amplitude, period, and baseline of tumour motion over a period of time were 
also shown to generate significant dose discrepancies [110,111].   
However, no work has yet to isolate and systematically categorize the different types of 
dose discrepancies resulting from tumour motion during helical tomotherapy.  Different 
types of motion-induced dose discrepancies should be investigated individually, in 
relations to different treatment and tumour motion parameters to gain better 
understanding for their causes.  Once a clear understanding for all potential types of dose 
discrepancies is established, the appropriate strategies to address these effects can be 
proposed and investigated.  Study of different types of motion-induced dose 
discrepancies due to tumour motion during helical tomotherapy is one of the most 
essential components of this thesis.2 
                                                 
2
 Different motion-induced dose discrepancies investigated in this thesis are summarized in Table 5.1. 
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1.5 Motion Management of Lung Tumours during Radiation 
Delivery 
In this section, both the traditional and new methods of defining motion-encompassing 
tumour volume will be discussed.  The different motion management techniques will then 
be described for both conventional radiotherapy techniques and helical tomotherapy. 
1.5.1 Use of Margins to Encompass Tumour Motion 
Traditionally, target volume delineation process follows the guidelines provided by the 
ICRU 62 [112].  A gross tumour volume (GTV) is defined as “the gross demonstrable 
extent and location of the malignant growth” that is visible on the planning images [98].  
A clinical target volume (CTV) expands on the GTV to include microscopic extensions 
surrounding the GTV, which are invisible on the images but nonetheless exist.  A 
planning target volume (PTV) is then produced by adding a margin around the CTV to 
account for all sources of intrafraction and interfraction uncertainties arising over the 
course of a radiation treatment.  There are a number of PTV margin “recipes” currently 
available, which propose the different weighting factors for the various systematic and 
random components of uncertainties to calculate the required PTV margin size [113]. 
In the presence of tumour motion, the PTV margin may be further divided into internal 
margin (IM) and set-up margin (SM).  An internal margin (IM) encompasses the 
intrafraction tumour motion, and interfraction variations of the CTV size, shape and 
position.  A set-up margin (SM) accounts for the patient set-up and beam positioning 
uncertainties.  One of the currently available image guidance methods discussed in 
Section 1.3 may be employed to minimize the PTV margin size.   
With the availability of more advanced imaging techniques, however, a new way of 
defining GTV to encompass tumour motion has emerged.  This motion-encompassing 
tumour volume may be referred to as the tumour motion envelope [114], or the internal 
gross tumour volume (IGTV) [115-119].  The philosophy behind this approach is to 
commence the tumour delineation process with a “correct” GTV, rather than accounting 
for tumour motion using internal margin (IM) at a latter stage.  “Slow” CT imaging 
utilizes a gantry rotation period comparable to a tumour motion period to capture the 
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entire motion extent of a tumour volume [120-122].  The slow CT scan is performed 
multiple times to ensure that the resulting tumour motion envelope represents the sum of 
tumour volumes at all of its probable positions.  Due to the use of a relatively slow gantry 
speed and large amount of data, however, the resulting slow CT images are subjected to 
significant motion-induced image artifacts, interfering greatly with an accurate 
delineation of the tumour envelope [114,123-125].  Gagne et al has demonstrated that the 
tumour envelope can still be determined accurately in the presence of image artifacts by 
only accepting a volume of pixels with intensity above a specific threshold [105]. 
With the advent of 4D-CT imaging technique, multiple CT datasets at different 
respiratory phases have become available clinically [85-89].  Thus, the GTV’s contoured 
from all respiratory phases can be combined to generate an internal gross tumour volume 
(IGTV).  Currently, at London Regional Cancer Program (LRCP), contouring is done at 
the end-expiration and end-inspiration phases to capture the tumour volume at its most 
extreme positions.  The two GTV’s are then combined with the GTV contoured on the 
“average” CT of all phases to generate the IGTV.  It has been shown that the IGTV 
produced from the end-expiration and end-inspiration phases alone may significantly 
underestimate the IGTV generated from all phases [119].  Alternatively, the IGTV can 
also be delineated on the maximum intensity projection (MIP) image from the different 
phases [116-119].  However, the MIP approach is not capable of isolating the tumour 
volumes that are located close to other structures, such as the diaphragm or mediastinum 
[116].  
1.5.2 Tumour Motion Management for Conventional Radiotherapy 
Techniques 
Accurate determination of the planning target volume (PTV) encompassing the entire 
tumour motion alone is not sufficient to account for the motion-induced dose 
discrepancies generated inside the PTV.  Thus, employing tumour motion management 
will be required to reduce the magnitude of dose discrepancies.  The currently available 
motion management techniques can be classified into breath-holding, respiratory gating, 
and tumour tracking. 
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1.5.2.1 Breath-Holding 
During a radiation treatment employing breath-holding, treatment beam is only turned on 
during breath-holds, and turned off between breath-holds to allow patients to resume 
normal breathing.  Patients undergo breath-holding at a planned respiratory phase, during 
which the tumour volume is temporarily immobilized inside the treatment field [126-139].  
To achieve breath-holding in a reproducible manner, patients are provided with assistance 
in the form of verbal instructions [130], a breathing-aid such as the active breathing 
control (ABC) device [131-135], a visual display of the patient’s own respiration trace 
[82,83], or different combinations of these aids.   
The respiratory phase for breath-holding may occur at deep-inspiration [126-134], normal 
inspiration [136,137], or end-expiration [131,138].  Deep-inspiration breath-holding has 
generally shown to yield high tumour position reproducibility, and displace the critical 
structures within the thoracic cavity, such as the heart and major blood vessels, away 
from the treatment field.  In addition, the total mass of normal lung tissues within the 
treatment field may decrease, as the lung tissue density approaches its minimum at deep-
inspiration.  However, patient discomfort remains a big issue for breath-holding, due to 
the poor pulmonary conditions of lung patients.  At Memorial Sloan-Kettering Cancer 
Center (MSKCC), a compliance rate of only 40% was reported for deep-inspiration 
breath-holding in 2000 [127].  Patient compliance rate may improve with normal 
inspiration breath-holding, but the aforementioned clinical advantages of deep-inspiration 
breath-holding may be greatly reduced.  With end-expiration breath-holding, tumour 
coverage may improve due to the increased lung tissue density, but at the expense of 
greater mass of normal tissues being irradiated.  However, it has been shown that the 
improved lung tissue sparing at deep inspiration is likely to outweigh the improved 
tumour coverage at end-expiration [139]. 
Due to the patient compliance issue for breath-holding, forced shallow breathing (FSB) 
may be employed to allow limited normal breathing [140-143].  In this approach, 
pressure is applied to the patient’s abdomen by a small plate attached to a stereotactic 
frame, thus limiting the extent of diaphragmatic motion.  Negoro et al has observed the 
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range of tumour motion to decrease from 8-20 mm (12.3 mm mean) to 2-11 mm (7.0 mm 
mean) with abdominal compression [142]. 
1.5.2.2 Respiratory Gating 
During a radiation treatment employing respiratory gating, the treatment beam is only 
turned “on” during a pre-determined portion of a tumour motion cycle, placing no 
constraints on patient breathing.  This pre-set portion of a tumour motion cycle, namely 
the gating window, may cover a range of tumour positions (amplitude gating) or phases 
within a respiratory cycle (phase gating), during which radiation delivery is enabled [144-
148].  Once the tumour volume moves out of the gating window, the treatment beam is 
turned off, until it returns again inside the gating window for a subsequent beam delivery.  
As the magnitude of tumour motion during radiation delivery becomes restricted to the 
residual motion [148] within a gating window, the impact of tumour motion during a 
gated dose delivery is greatly reduced.   
Selecting an appropriate gating window size is based on a tradeoff between accuracy and 
efficiency of dose delivery.  Use of a very small gating window will effectively “freeze” 
the tumour motion during radiation delivery, allowing for an accurate dose delivery to be 
made to the tumour volume.  However, this occurs at the expense of significantly 
prolonging the treatment session time.  The gating window is normally positioned around 
the end-expiration phase, as a moving tumour volume typically slows down during 
expiration and reaches its minimum velocity at the end-expiration.  Thus, placing a gating 
window around the end-expiration phase yields a smaller residual motion, compared to 
other respiratory phases [144].   
1.5.2.3 Tumour Tracking 
During a radiation treatment employing tumour-tracking, the moving tumour volume is 
continuously irradiated by dynamically moving a treatment beam according to tumour 
position [149-155].  As a result, no constraints are placed on patient breathing, and unlike 
breath-holding and respiratory gating, the treatment session time is comparable to a 
radiation treatment session time without motion management.  Beam repositioning may 
be achieved through the use of a dynamic MLC [149-154], or a robotic arm [155] moving 
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a miniature linear accelerator.  In the remainder of this thesis, the MLC repositioning 
method will be referred to as the tumour tracking method.  
Clinical implementation of tumour tracking dose delivery requires the use of a real-time 
tumour monitoring system (Section 1.3.5), and a predictive algorithm [156-161].  A 
predictive algorithm is used to anticipate the “near-future” tumour position in advance, 
accounting for the time required to determine and execute appropriate MLC movements 
after detecting the tumour location.  For a conventional MLC system, the leaf response 
latency and the actual leaf transition time combine to yield a total latency in the range of 
100-200 ms [20].  Thus, the accuracies of tumour monitoring and the predictive 
algorithm become crucial to ensure an appropriate synchrony is established between 
tumour motion and corresponding leaf actions, so that significant dose discrepancies can 
be avoided. 
1.5.3 Tumour Motion Management for Helical Tomotherapy 
Employing any of the aforementioned motion management techniques in Section 1.5.2 
becomes more complicated for helical tomotherapy, due to its continuously moving 
subsystems (gantry, couch, and b-MLC).  In the past, different motion management 
methods [162-167] have been proposed for helical tomotherapy, but none of them have 
been implemented clinically as of yet.   
In the “gating-by-rotation” approach, dose delivery during each gantry rotation occurs, 
while the patient undergoes breath-holding.  Each gantry rotation with breath-holding is 
then followed by a “non-treatment” gantry rotation, during which the couch movement is 
temporarily halted and the b-MLC leaves remain fully closed to permit normal breathing 
[162,163].  At the start of the subsequent gantry rotation, both breath-holding and couch 
motion resume for dose delivery.  The same process is repeated, until the entire tumour 
volume is treated.   
Tumour motion information may be incorporated a priori during the plan optimization 
process, allowing for a pre-planned tracking of the tumour volume by the binary MLC (b-
MLC) during treatment [164,165].  However, the same tumour motion pattern used 
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during planning must be reproduced during each treatment fraction to avoid significant 
dose discrepancies.  Real-time tumour tracking has also been proposed for helical 
tomotherapy [166,167].  In this method, the longitudinal motion component is 
compensated by “shuffling” and executing the sequence of planned beam projections 
assigned with the same gantry angles out-of-order, according to the detected longitudinal 
tumour location.  The change in lateral tumour position is accounted for by delivering the 
same planned fluence through different leaves. 
1.5.4 Limitations of the Proposed Tumour Motion Management 
Approaches for Helical Tomotherapy 
With the “gating-by-rotation” approach, halting the couch motion during treatment 
introduces an additional couch position uncertainty and potential beam junctioning, as 
well as potentially altering the patient position.  Although the couch position uncertainty 
introduced during each stoppage may be small, the uncertainty accumulated over multiple 
start-stops may become significant.  The use of a large pitch factor to reduce or eliminate 
the interruptions of couch movement may be more feasible clinically, and this becomes 
another objective of this thesis. 
Although incorporating tumour motion information during the plan optimization process 
is an innovative way to track the tumour volume in a pre-planned manner, it will be very 
difficult to reproduce the identical tumour motion pattern during each treatment fraction.  
For real-time tumour tracking method, “shuffling” the beam projections to treat the 
different slices within the volume out-of-order does not compensate for the radiological 
pathlength differences encountered by the original and shifted beam projections.  As each 
spatially shifted beam projection encounters different tissue density and thickness, the 
beam attenuation will be affected, preventing the intended dose from being delivered to 
the tumour volume – especially for large amplitudes of tumour motion.  This tissue 
attenuation issue may be avoided by employing respiratory gating over tumour tracking.  
Feasibility study of respiratory gating for helical tomotherapy is one of the primary 
objectives of this thesis.  
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Due to the continuous motions of the gantry and treatment couch during helical 
tomotherapy, the dose undelivered at a particular gantry angle and couch position cannot 
be recovered, unless the gantry rotation and couch motion are interrupted.  The only way 
to make up for the “missing” dose without introducing treatment interruptions is to repeat 
the entire treatment.  Thus, the two new approaches presented in the current thesis utilize 
multiple passes of helical tomotherapy dose delivery to complete the planned dose 
distribution to the tumour volume.   
1.6 Research Objectives 
The research work done in this thesis was focused on the following objectives: 
1. Define the different types of dose discrepancies resulting from tumour motion 
during helical tomotherapy, and investigate the characteristics of each dose 
discrepancy individually, in relations to different treatment and tumour motion 
parameters, through computer simulations and experimental measurements using 
film dosimetry. 
2. Describe and investigate the dosimetric characteristics of the loose helical 
tomotherapy delivery with breath-holding, simulated on a linear accelerator (prior 
to the arrival of the helical tomotherapy unit at LRCP), through treatment planning 
and experimental measurements using film dosimetry.   
3. Describe and investigate the feasibility of employing multi-pass respiratory gating 
technique for helical tomotherapy, through computer simulations and experimental 
measurements using film dosimetry on the helical tomotherapy machine. 
1.7 Research Hypothesis 
Respiratory gating or breath-holding techniques can be applied to helical tomotherapy to 
reduce the different sources of dose discrepancies caused by tumour motion. 
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1.8 Scope of the Thesis and Thesis Roadmap 
Target volume investigated in this thesis work represents a lower lung tumour located 
close to the diaphragm, thus exhibiting predominant motion along the superior-inferior 
(SI) direction, driven by diaphragmatic motion.  Thus, all motion patterns investigated in 
this thesis displayed 1D target motion, only along the SI direction.  All the experimental 
measurements were performed with sinusoidal target motion, while both sinusoidal and 
non-sinusoidal motion patterns were employed for computer simulations.  No 
inhomogeneity was introduced by assuming a target volume that is surrounded by water-
equivalent tissues, instead of lung tissues. 
In Chapter 2: “Motion-induced dose artifacts in helical tomotherapy”, the different types 
of dose discrepancies resulting from tumour motion during helical tomotherapy are 
defined, and their characteristics are investigated individually, in relations to different 
treatment and tumour motion parameters.  The work in this chapter is based on a 
publication, “Kim B, Chen J, Kron T, and Battista J (2009) Motion-induced dose artifacts 
in helical tomotherapy. Phys Med Biol 54, 5707-34.”  In Chapter 3: “Investigation of 
dose homogeneity for loose helical tomotherapy delivery in the context of breath-hold 
radiation therapy”, the loose helical tomotherapy delivery with breath-holding is 
described, along with its dosimetric characteristics.  The work in this chapter is based on 
a publication, “Kim B, Kron T, Battista J, and Van Dyk J (2005) Investigation of dose 
homogeneity for loose helical tomotherapy delivery in the context of breath-hold 
radiation therapy. Phys Med Biol 50, 2387-404.”  In Chapter 4: “Feasibility study of 
multi-pass respiratory-gated helical tomotherapy of a moving target via binary MLC 
closure”, the multi-pass respiratory gating technique is described.  The proposed 
technique is investigated, in terms of its effectiveness for reducing the magnitude of 
different motion-induced dose discrepancies described in Chapter 2.  The work in this 
chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista J (2010) 
Feasibility study of multi-pass respiratory- gated helical tomotherapy of a moving target 
via binary MLC closure. Phys Med Biol 55, 6673-94.”  In Chapter 5: Summary and 
Conclusions, major findings from each of Chapter 2, 3, and 4 are summarized.  The 
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clinical implications and the limitations of the proposed methods and the work done in 
this thesis are discussed, as well as the future work. 
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Chapter 2  
2 Motion-Induced Dose Artifacts in Helical Tomotherapy 
The work in this chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista 
J (2009) Motion-induced dose artifacts in helical tomotherapy. Phys Med Biol 54, 5707-
34.” http://dx.doi.org/10.1088/0031-9155/54/19/004 
2.1 Introduction 
2.1.1 Helical Tomotherapy 
Helical tomotherapy [1,2] is a novel radiation therapy technique, which utilizes a 
continuously rotating gantry and a linearly moving couch to irradiate a target volume in a 
helical manner.  As the treatment couch advances into the gantry bore along the 
longitudinal direction (Y), the target volume is irradiated in slices using a fan beam of 
radiation.  At the axis of gantry rotation (SAD = 85 cm), a two-stage collimation 
produces a fan beam field with a projected width of 40 cm (X = 40 cm) and a selectable 
fan beam thickness of 1.05 cm, 2.5 cm, or 5.0 cm along the longitudinal direction (Y).  
The fan beam is further divided into 64 beamlets with each beamlet being 0.625 cm wide 
at the axis of gantry rotation (40 cm / 64 = 0.625 cm), using a binary multi-leaf collimator 
(b-MLC).  The b-MLC consists of 64 interlaced binary leaves (32 on each side of the axis 
of gantry rotation), which can be either fully open or fully close with a leaf transit time of 
about 15 ms [3,4].  Radiation fluence passing through each beamlet is thus controlled by 
the duration of time for which its corresponding leaf remains open (i.e. leaf opening 
time).  Every gantry rotation during a helical tomotherapy treatment is divided into 51 
equally-spaced beam projections (each spanning ~70) for the purpose of intensity 
modulation.  Intensity modulation is then achieved by assigning a specific value of leaf 
opening time as a function of beam projection and leaf number.  The duration of leaf 
opening time is centered about the mid-point of each beam projection period, with the 
leaf remaining closed during the start and end of the beam projection period.    
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2.1.2 Tumour Motion 
The presence of tumour motion during the radiation therapy of lung cancer is a well-
documented problem.  In the past, various approaches have been proposed to minimize 
the effect of respiratory-driven tumour motion during conformal radiation therapy [5-8], 
IMRT [9,10], and helical tomotherapy [4,11-13] treatments.  Inferiorly positioned lung 
tumours typically exhibit the greatest range of motion along the superior-inferior (SI) 
direction of the patient, due to their proximity to the diaphragm and the resulting 
influence of the diaphragmatic motion.  Peak-to-peak magnitude of such tumour motion 
can approach several cm’s with a typical period of 3-5 s [14-17].  The SI motion 
component coincides with the longitudinal direction of the couch motion, and thus 
interferes directly with the “slice-to-slice” irradiation of the target volume during a 
tomotherapy delivery.  This motion-induced interference can lead to various types of 
dose discrepancies between the delivered and plan dose distributions [18-21].  Dose 
discrepancies can also result from the anterior-posterior (AP) and left-right (LR) 
components of tumour motion.  Although the correct slices of the target volume are still 
being irradiated in the presence of these motions, the plan dose is not correctly deposited 
in the planning target volume (PTV).  In this work, however, we will be focusing on the 
SI target motion only, as it is the predominant motion component that can potentially 
produce the most significant dose discrepancies.  
2.1.3 Different Types of Motion-Induced Dose Discrepancies 
In the present study, three different types of motion-induced dose discrepancies are 
defined specifically for helical tomotherapy, namely (1) dose rounding, (2) dose rippling, 
and (3) IMRT leaf opening asynchronization effect.  Dose rounding [18,21] is the 
penumbral widening of a delivered dose distribution near the edges of a target volume 
along the direction of tumour motion.  In the presence of longitudinal target motion, the 
penumbral increase leads to the under-dosing of the target volume near its longitudinal 
boundaries, and over-dosing of the surrounding normal structures just outside the target 
volume.  Dose rounding becomes more pronounced with the increasing amplitude of 
tumour motion.   
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Dose rippling [18-20] is a series of periodic dose peaks and valleys present within the 
target region along the direction (Y) of couch motion.  Dose rippling is observed for 
tomotherapy cases both with and without intensity modulation (i.e. IMRT and non-IMRT 
cases).  Dose rippling occurs due to an asynchronous interplay between the couch motion 
and the longitudinal tumour motion with a fixed frequency.  When the interplay is 
synchronous, dose rippling becomes absent for the non-IMRT cases, while being 
significantly reduced for the IMRT cases.  For the non-IMRT cases, constant leaf 
opening time means that the dose losses due to motion are always compensated by the 
identical dose gains (and vice versa) for synchronous conditions, which leads to the 
absence of dose rippling.  On the other hand, the variable durations of leaf opening time 
during an IMRT delivery cause the dose gains to differ from the dose losses.  Thus, 
although the magnitude of dose rippling is significantly reduced for synchronous 
conditions, the differences still exist between the planned and delivered dose 
distributions.   
The IMRT leaf opening asynchronization effect is an additional effect caused by an 
asynchronous interplay between the temporal patterns of leaf openings and the 
longitudinal target motion.  Unlike dose rippling, the IMRT leaf opening 
asynchronization effect does not exhibit any periodicity, and its resulting dose 
distribution pattern is highly specific and unique to each tomotherapy plan (i.e. leaf 
opening pattern).  The paper by Kanagaki et al [21] was the only study that investigated 
the effect of tumour motion for IMRT helical tomotherapy deliveries.  However, the 
IMRT leaf opening asynchronization effect was not observed in this particular work, and 
hence we characterized a new and significant dose discrepancy associated with IMRT 
tomotherapy deliveries.      
2.1.4 Purpose 
In the present study, the characteristics of the three aforementioned dose discrepancies 
were investigated as functions of target motion amplitude and period for both non-IMRT 
and IMRT helical tomotherapy cases in the presence of sinusoidal target motion.  The 
non-IMRT cases were investigated to allow for the dose rounding and dose rippling 
effects to be studied separately.  A computer simulation model was developed to 
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calculate longitudinal dose profiles along the axis of gantry rotation inside a body 
phantom, and to be used as a tool to predict the dosimetric effect of tumour motion 
during a helical tomotherapy delivery.  Experimental verification was then carried out on 
the helical tomotherapy unit, using a motion body phantom and dosimetric film.  The 
dosimetric characteristics of dose rounding and dose rippling were also studied as a 
function of target motion amplitude. 
2.2 Materials and Methods 
2.2.1 Helical Tomotherapy Plans 
In this section, the parameters related to helical tomotherapy and tumour motion will be 
defined.  The nature of leaf opening sinogram will be explained.  The non-IMRT and 
IMRT helical tomotherapy plans used in this study to investigate the effect of target 
motion will be also described. 
2.2.1.1 Helical Tomotherapy and Tumour Motion Parameters 
The treatment parameters associated with helical tomotherapy include pitch factor (p), 
fan beam thickness (b), gantry rotation period (Tg), and number of gantry rotations (R).  
Pitch factor (p) is defined as the progression distance of the longitudinal couch motion 
per gantry rotation in units of fan beam thickness (b).  Gantry rotation period (Tg) is the 
time required to complete one full gantry rotation; the current helical tomotherapy unit 
allows for selectable periods (Tg) between 15 and 60 s, with a gantry rotation period of 15 
to 20 s being used clinically for the helical tomotherapy of lung cancer [22].  Number of 
gantry rotations (R) is the number of gantry rotations required to treat the target volume 
during the treatment.  The parameters related to tumour motion are amplitude (A) and 
period (Tr).  Amplitude (A) is defined as the one-half of the peak-to-peak amplitude (2A) 
of tumour motion along the longitudinal direction (+Y), while tumour motion period (Tr) 
is the time required to complete one full cycle of tumour motion.  
2.2.1.2 Leaf Opening Sinogram 
During a helical tomotherapy treatment, intensity modulation is carried out according to 
the leaf opening time information stored in the form of a leaf opening sinogram.  The leaf 
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opening sinogram is a two-dimensional matrix of leaf opening time values, where the row 
and column indices represent leaf number and beam projections, respectively.  In this 
study, a user-created leaf opening sinogram was utilized for the non-IMRT cases, while a 
leaf opening sinogram for the IMRT cases was generated by the helical tomotherapy plan 
optimizer (TomoTherapy version 2.2.2, TomoTherapy Inc., Madison, WI). 
2.2.1.3 Non-IMRT Helical Tomotherapy Plan 
The current helical tomotherapy unit (HI-ART II) allows the user to enter a leaf opening 
sinogram directly at the treatment console for a radiation delivery.  In order for the leaf 
opening sinogram to be accepted at the treatment console, the leaf opening sinogram 
must contain values of relative leaf opening time.  Relative leaf opening time (T0) is 
defined as the ratio of the actual leaf opening time (Ta) for a beam projection to the 
maximum leaf opening time per beam projection (Tm):     
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where T0 is the relative leaf opening time for a beam projection, Ta is the actual leaf 
opening time for the beam projection, Tm is the maximum leaf opening time per 
beam projection, Tg is the gantry rotation period, and n is the number of beam 
projections per gantry rotation (n = 51).  
For the non-IMRT plan, the planning target volume (PTV) was assumed to be a 5.5 cm-
long cylinder centered along the axis of gantry rotation inside the body phantom (Modus 
Medical Devices Inc., London, Canada) shown in Figure 2.1 a), which mimicked a 
human torso.  The four central leaves were assigned with the maximum leaf opening time 
(T0 = Tm = 1.00) for all beam projections, while the rest of the leaves remained fully 
closed (T0 = 0.00) during the entire treatment, using a fan beam thickness (b) of 2.5 cm.  
A fixed value of leaf opening time was assigned for each individual leaf, so that a 
uniform fluence was delivered only along the central axis of the PTV.  Using a pitch 
factor of 0.8 (p = 0.8), four full gantry rotations (R = 4) were required to treat the PTV, 
and a gantry rotation period of 16 s (Tg = 16 s) was selected.  A pitch factor of 0.8 was 
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selected rather than the typically used pitch factor of less than 0.3 for lung cancer 
tomotherapy [22], in order to produce specific conditions for studying the dose rippling 
effect described in Section 2.1.3.   
2.2.1.4 IMRT Helical Tomotherapy Plan 
An IMRT helical tomotherapy plan was generated using the CT images of a body 
phantom (ρ = 1.18 g/cm3, length = 12 cm, width = 30 cm, height = 20 cm) in Figure 2.1 
a).  On the CT images of the body phantom (Figure 2.1 b), a virtual 3.6 cm-long 
cylindrical organ at risk (OAR) was delineated to be wrapped around by a 6.6 cm-long C-
shaped planning target volume (PTV).  Contouring of the PTV, the OAR, and the 
phantom outline was performed in a commercial treatment planning system (Pinnacle 
8.0d, Philips Medical Systems).  The CT images and contours were then exported to the 
tomotherapy treatment planning system (TomoTherapy version 2.2.2, TomoTherapy Inc., 
Madison, WI), where a dose of 2.0 Gy was prescribed to 95 % of the PTV with the 
maximum OAR dose being limited to 0.8 Gy.  A pitch factor (p) of 0.287 (i.e. 0.86 / 3) 
was selected to minimize the “thread artifact” [23], and a fan beam thickness of 2.5 cm 
was chosen.  During the tomotherapy plan optimization process, the values of leaf 
opening time needed to optimize the plan were calculated for each of the 64 b-MLC 
leaves as a function of beam projection, yielding the planned dose distribution shown in 
Figure 2.1 c).   
At the end of the plan optimization, the generated leaf opening sinogram contained sums 
of leaf opening time for all fractions of a treatment (i.e. actual leaf opening time per 
fraction * number of fractions) over 819 beam projections (R ~ 16), with the matrix rows 
and columns representing beam projections and leaf number, respectively.  The leaf 
opening sinogram was then truncated to shorten the length of the PTV from 6.6 cm to 
3.24 cm, so that the resulting PTV region fell well within the length of the body phantom 
with the motion amplitudes used in this study.  This was done by eliminating the first 252 
and the last 159 beam projections, yielding a plan with 408 beam projections (R = 8) and 
a plan dose of 1.75 Gy instead of 2.0 Gy.  This was deemed acceptable, as the objective 
of this study was not to reproduce a particular plan, but to investigate how motion affects 
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a given plan.3  In order to make the modified leaf opening sinogram to be accepted at the 
treatment console, each value of leaf opening time was converted to relative leaf opening 
time, and the entire leaf opening sinogram matrix was then transposed (i.e. indexed by 
leaf number, beam projection).  
 
Figure 2.1: IMRT helical tomotherapy plan for a stationary target a) Photograph of 
the lucite body phantom (ρ = 1.18 g / cm3, length = 12 cm, width = 30 cm, height = 20 
cm) mimicking a human torso, b) Transverse (top) and coronal (bottom) CT images 
of the body phantom with the contours of the PTV (dark), OAR (light), and the 
phantom outline.  The film insert remained stationary inside the body phantom at 
its mid-position during the CT scanning process. c) Plan dose distributions on the 
transverse and coronal planes.  Dose of 2.0 Gy was prescribed to 95% of the PTV 
with the maximum OAR dose being limited to 0.8 Gy.   
                                                 
3
 The delivered dose distribution in Figure 2.7 (b) for the (i) “no motion” case appears different from the 
plan coronal dose distribution shown in Figure 2.1 (c), due to the truncation process as well as the resulting 
shift in gantry angle. 
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2.2.2 Computer Simulation 
A computer simulation program was developed in MATLAB (Mathworks, Natick, MA), 
as a tool to study and predict the dosimetric effect of longitudinal target motion during a 
helical tomotherapy delivery.  The computer simulation model was designed to calculate 
dose profiles along the axis of gantry rotation for both non-IMRT and IMRT helical 
tomotherapy irradiations of the body phantom (Figure 2.1 a).  A similar study for helical 
tomotherapy was first published by Kissick et al [20], which was an extension of the 
work done by Yu et al [19] for the sliding window technique.  The concept used by Yu et 
al [19] was applicable to the present study and to the study by Kissick et al [20], since the 
set-up for the sliding window technique in the presence of lateral motion was analogous 
to that of helical tomotherapy in the presence of longitudinal motion.  For simplicity, we 
investigated the effect of target motion with a sinusoidal pattern, and this model was 
general enough to handle any type of motion pattern.  
2.2.2.1 Coordinate System 
The tumour coordinate system (Figure 2.2 b) was adopted for the computer simulation 
model in this study, instead of the room coordinate system (Figure 2.2 a) used by Kissick 
et al [20].  In the room coordinate system (Figure 2.2 a), the tumour position, Y(t) is 
determined by the linear motion of the treatment couch combined with the periodic 
motion of the tumour volume itself:  
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where Ycouch(t) is the position of the treatment couch as a function of time, Ytumour(t) 
is the position of the tumour volume on the treatment couch as a function of time, p 
is the pitch factor, b is the fan beam thickness, Tg is the gantry rotation period, Tr is 
the period of tumor motion, and A is the amplitude of tumour motion along the 
longitudinal (+Y) direction. 
In the tumour coordinate system (y) shown in Figure 2.2 b), the tumour volume remains 
stationary, while the “moving” treatment field assumes the roles of both couch motion 
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and tumour motion.  The two fan beam edges, leading beam edge yL (t) and trailing beam 
edge yT (t) move along the longitudinal direction (+y) with respect to the center of the 
tumor volume according to the following equations:  
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where yT (t) and yL (t) are the positions of the trailing and leading beam edges as 
functions of time, respectively, D is the total couch travel during the treatment, and R 
is the number of gantry rotations used during the treatment.  
 
Figure 2.2: Coordinate systems for a moving target: a) In the room coordinate 
system, the tumour position (Y) with respect to the stationary fan beam is governed 
by the linear motion of the treatment couch, combined with the periodic motion of 
the tumour volume itself, as summarized in Equation 2.2, b) In the tumor 
coordinate system (y), the target volume remains stationary, while the “moving” 
treatment field assumes the roles of both couch motion and tumor motion.  The two 
fan beam edges (trailing beam edge, yT(t) and leading beam edge, yL(t)) move along 
the longitudinal direction (+y) with respect to the center of the tumor volume 
according to Equation 2.3. 
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2.2.2.2 Computer Simulation Model 
The dose received by each longitudinal point (y) along the axis of gantry rotation was 
determined by first calculating the radiation exposure time.  In Figure 2.3, a set of solid 
lines observed at each longitudinal position represents the irradiation time (“ON”) of the 
corresponding point, while the dotted lines indicate the time spent outside the 
longitudinal beam edges (“OUT”).  Thus, the radiation exposure time (∆t) was calculated 
by summing up the temporal lengths of all solids lines: 
 ( ) ( )∑
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where ∆t(y) is the radiation exposure time at a given longitudinal position (y), m is 
the number of solid lines at each longitudinal position (y), and ∆ti is temporal length 
of the ith solid line. 
For the non-IMRT helical tomotherapy cases shown in Figure 2.3 a) and b), the irradiated 
time (“ON”) was equal to the time spent inside the two fan beam edges (“IN”), since the 
radiation beam was fully on during the entire treatment by assigning the maximum leaf 
opening time for all beam projections (T0 = 1.00).  For the IMRT helical tomotherapy 
delivery in Figure 2.3 c), the irradiated time (“ON”) was the temporal overlaps between 
the time spent inside the beam edges (“IN”) and the “Beam ON” windows, making “ON” 
a subset of “IN”.  The widths of the “Beam ON” windows were determined by the values 
of leaf opening time assigned as a function of leaf number and beam projection.  The 
temporal length (∆ti) of each solid line (“ON”) was calculated numerically by comparing 
the longitudinal position of the given point to the positions of the beam edges and the 
“Beam ON” windows in temporal increments of 1 ms.  The radiation exposure time (∑
∆ti) of each point was then determined by summing up the lengths of all the irradiated 
time segments (∆ti’s).  The radiation exposure time calculation was repeated in spatial 
increments of 0.01 cm to produce a radiation exposure time versus position profile. 
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Figure 2.3: (a) Position vs. time curves of the longitudinal beam edges for a non-
IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target (Tr = 4 s, A = 
0.5 cm) in the tumour coordinate system (y), under a synchronous interplay 
condition (β = integer = 5).  A set of solid lines observed at each longitudinal position 
represents the irradiated time (“ON”) of the corresponding point, while the dotted 
lines indicate the time spent outside the longitudinal beam edges (“OUT”).  In non-
IMRT cases, the irradiated time (“ON”) is equal to the time spent inside the two fan 
beam edges (“IN”), since the radiation beam remains fully on during the entire 
treatment (T0 = 1.00).  The temporal length (∆ti) of each solid line (“ON”) was 
calculated numerically by comparing the longitudinal position of the given point to 
the positions of the beam edges in temporal increments of 1 ms.  The radiation 
exposure time (∆t) of each point was then determined by summing up the lengths of 
all irradiated time segments (∆ti’s).  (b) Position vs. time curves of the longitudinal 
beam edges for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a 
central target (Tr = 8 s, A = 0.5 cm) in the tumour coordinate system (y), under an 
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asynchronous interplay condition (β ≠ integer = 2.5).   (c) Position vs. time curves of 
the longitudinal beam edges for an IMRT helical tomotherapy (p = 0.287, Tg = 15 s, 
R = 8) of a central target (Tr = 8 s, A = 1.0 cm) in the tumour coordinate system (y).  
The irradiated time (“ON”) was the temporal overlaps between the time spent inside 
the beam edges (“IN”) and the “Beam ON” windows, making “ON” a subset of 
“IN”.  The widths of the “Beam ON” windows were determined by the values of leaf 
opening time assigned as a function of leaf number and beam projection.  
The resulting longitudinal exposure time versus position profile was converted directly 
into a longitudinal fluence profile by assuming a constant fluence rate.  The fluence 
profile, Φ(y) was then converted to a longitudinal dose profile, D(y) via one-dimensional 
convolution using an empirically determined dose kernel, K(y): 
 )()()( yyKyD Φ⊗=  (2.5) 
where D(y) is the dose profile, K(y) is the dose kernel, and Φ(y) is the normalized 
fluence profile. 
The normalized fluence profile Φ(y) was assumed to be rectangular in shape along the 
direction.  The dose kernel, K(y) was then derived using a dose profile along the axis of 
gantry rotation, acquired experimentally using Kodak EDR2 film.  A piece of film was 
placed inside the stationary film insert within the body phantom (Figure 2.1 a), and 
irradiated for one full gantry rotation (Tg = 15 s) with the treatment couch remaining 
stationary during the radiation delivery.  The dose kernel was a set of exponential 
functions resembling the primary beam penumbra equations defined by Cunnigham [24] 
and used by a commercial treatment planning system (Theraplan Plus v.3.0, 1998) [25].  
The dose profile calculated with the dose kernel, K(y) was fitted manually to the 
measured dose profile by continuously varying the coefficient values of the different 
parameters in the dose kernel, K(y).  The fitting process was repeated until the root-mean-
square (RMS) of the absolute differences between the entire calculated and measured 
dose profiles was less than 1.2 %. 
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2.2.2.3 Dose Rippling Parameter (β) 
Dose rippling was one of the three motion-induced dose discrepancies investigated in this 
study.  The dose rippling parameter, β was defined as a tool to quantify the presence of 
dose rippling by determining the nature of interplay (asynchronous or synchronous) 
between the couch motion and tumour motion.  The dose rippling parameter, β was 
defined as the ratio of the time required (Tg / p) for the couch to travel a distance of one 
fan beam thickness (b) to the target motion period (Tr): 
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where p is the pitch factor, Tg is the gantry rotation period, and Tr is the period of 
tumour motion.   
A synchronous interplay is established when there is an integer number of target motion 
cycles completed during the time span Tg / p (i.e. β = integer).4   For a non-IMRT 
tomotherapy delivery, a synchronous condition leads to the uniform irradiation of the 
target along the axis of gantry rotation, and thus the absence of dose rippling – proved 
mathematically in Appendix A.5  A similar mathematical relationship to Equation (2.6) 
was also defined for the sliding window technique in the study by Yu et al [18].  In 
Figure 2.3 a), the uniform irradiation of the target under the synchronous condition (β = 
5) is indicated by the identical radiation exposure time for the target points, y = -1.8 cm 
and 0.5 cm, i.e. ∑∆ti (-1.8) = ∑∆ti (0.5).  At the target point, y = -1.8 cm, the temporal 
lengths of the five solid lines add up to the sum of the three solid lines at y = 0.5 cm.  At 
y = -1.8 cm, the dotted line between the first two solid lines is the same length as the 
fourth solid line, making them interchangeable with each other in position.  The dotted 
line between the second and third solid lines is then switched with the fifth solid line due 
                                                 
4
 An example of a synchronous interplay condition is shown in Figure 2.5 (b), while an asynchronous 
condition is presented in Figure 2.6 (b). 
5
 The absence of dose rippling under a synchronous condition also applies for periodic, non-sinusoidal 
target motion. 
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to their identical lengths, overall yielding a single solid line ranging from t = 4.55 s to t = 
24.55 s for the radiation exposure time of 20 s, i.e. ∑∆ti (-1.8) = 20 s.  At y = 0.5 cm, the 
dotted line between the first and second lines could be interchanged with the third solid 
line, while the dotted line between the second and third solid lines is switched with the 
first solid line.  As a result, a single solid line covering from t = 26 s to t = 46 s is 
produced for the radiation exposure time of 20 s as well, i.e. ∑∆ti (0.5) = 20 s = ∑∆ti (-
1.8).  In Figure 2.3 b), the asynchronous interplay condition (β ≠ integer = 2.5) results in 
the non-uniform radiation delivery to the target volume.  This is illustrated by the two 
selected target points, y = -2.0 cm and 0.4 cm receiving different radiation exposure, i.e. 
∑∆ti (-2.0) ≠ ∑∆ti (0.4), which leads to the presence of dose rippling.   
2.2.3 Experimental Verification 
2.2.3.1 Motion Body Phantom 
A motion body phantom (Modus Medical Devices Inc., London, Canada) shown in 
Figure 2.4 was used to verify the simulation results for the non-IMRT and IMRT helical 
tomotherapy cases listed in Table 2.1.  The motion phantom consisted of a lucite body 
phantom (ρ = 1.18 g/cm3, length = 12 cm, width = 30 cm, height = 20 cm), and a 
sinusoidally moving lucite film insert (ρ = 1.18 g/cm3, length = 18 cm, diameter = 8 cm) 
representing a tumour mass.  The film insert was designed to hold a piece of film (length 
= 15 cm, width = 6 cm) inside it, and contained five pins at its inside corners (2 at one 
corner and 1 at each of the three corners) to generate pinprick landmarks on each film.  
These fiducial marks were later used in the data analysis stage to align a pair of scanned 
film images for directly comparing the two dose distributions.  The film insert was 
positioned to move through the central opening of the body phantom, with the film 
placed on the coronal plane.  The amplitude of the film insert motion was set by adjusting 
the position of the translation stage holding film insert.  The motion phantom was also 
equipped with a “chest-height” platform, whose vertical up-and-down motion represented 
the anterior-posterior (AP) motion of a “chest wall”.  The “chest-height” platform moved 
with an identical period as the film insert.  Thus, the period of the film insert motion was 
verified by measuring the positions of the optical markers placed on the platform, using 
an optical tracking camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz.  
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Table 2.1: List of non-IMRT and IMRT helical tomotherapy cases. 
 
 
Figure 2.4: Experimental verification setup for a moving target.  The motion body 
phantom (Modus Medical Devices Inc., London, ON) consisted of the lucite body 
phantom, and a sinusoidally moving lucite film insert (length = 18 cm, diameter = 8 
cm) representing a tumour mass.  The film insert was designed to hold a piece of 
film (length = 15 cm, diameter = 6 cm) inside it.  The motion phantom was also 
equipped with a “chest-height” platform that moves with an identical period as the 
film insert.  The period of the film insert motion was verified by measuring the 
positions of the optical markers placed on the platform, using an optical tracking 
camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz. 
53 
 
2.2.3.2 Calibration of Film Dosimetry 
For each film experiment, a calibration procedure was carried out with a 6 MV helical 
tomotherapy X-ray beam, using a cylindrical solid water “Cheese” phantom 
(TomoTherapy Inc., Madison, WI, length = 18 cm, diameter = 30 cm).  A 10” x 12” 
EDR2 film was placed inside the phantom, and the couch height was adjusted to position 
the film on the isocentrical coronal plane.  The calibration procedure delivered eight 3 
cm2 square fields with known dose of 30.5 cGy, 65.2 cGy, 100.9 cGy, 128.2 cGy, 159.5 
cGy, 188.9 cGy, 215.0 cGy, and 244.4 cGy.  The calibration film was processed along 
with a blank film to enable background subtraction.  The developed films were then 
scanned with a Vidar VXR-16 DosimetryPro scanner (Vidar Systems Corporation, 
Herndon, VA) and analyzed with the RIT113 V4 software (Radiation Therapy Dosimetry 
Software, Colorado Springs, CO).  A region of interest (ROI) of 2 cm2 was placed inside 
each of the eight different fields on the calibration film and within the blank film.  The 
average optical density (OD) was then calculated for each ROI to generate an OD versus 
dose calibration curve.  
2.2.3.3 Radiation Delivery 
All the film experiments were carried out in the non-clinical mode at the helical 
tomotherapy unit.  An electronic communication was established between the 
tomotherapy machine and the motion phantom through a cable, such that the film insert 
motion would commence once the gantry angle reached zero.  The initial phase of the 
film insert motion was set at zero for all non-IMRT and IMRT cases by positioning the 
film insert in its mid-position before the start of each radiation delivery.      
2.2.3.4 Uncertainty Analysis 
Five repeated “no motion” measurements for the non-IMRT cases (p = 0.8, Tg = 16 s) 
were used to calculate the dose uncertainty inside the PTV.  The measured dose profiles 
were realigned to ensure that the center of the PTV in each dose profile matched with 
those from the other dose profiles.  A standard deviation was calculated for each dose 
point, and then the mean of all the standard deviations values were determined to 
represent the dose uncertainty of the film experiment in this study. 
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2.3 Results and Discussion 
2.3.1 Non-IMRT Helical Tomotherapy Cases 
2.3.1.1 Dose Rounding Effect 
In Figure 2.5 a), dose rounding effect6  was illustrated in the measured coronal dose 
distribution of a non-IMRT helical tomotherapy delivery.  In the “no motion” dose 
distribution (i), thread artifact7 was manifested as a series of dose ripples near the outer 
edges of the dose distribution along the longitudinal direction (y).  In the “motion” dose 
distribution (ii), the dose rounding effect due to the longitudinal target motion led to the 
“blurring” of a thread artifact, reducing the magnitude of off-axis dose ripples. The 
presence of dose rounding effect was illustrated in the dose difference map (iii) between 
the two dose distributions (“motion” dose distribution (i) – “no motion” dose distribution 
(ii)).  Underdosing was observed near the longitudinal PTV boundaries, while the regions 
both superior and inferior to these boundaries experienced overdosing.  Dose profiles 
along the axis of gantry rotation (dotted line, x = 0 cm) were generated from the dose 
distributions (i) and (ii) to further characterize the dose rounding effect. 
As shown in Figure 2.5 b), the measured and simulated dose profiles both exhibited dose 
rounding near the PTV boundaries due to the large peak-to-peak amplitude of target 
motion (2A = 2.0 cm).  The dose rounding effect resulted in the underdosing of the PTV 
near its boundaries, and overdosing of the surrounding normal structures just outside the 
PTV boundaries.  As shown in Figure 2.5 b), dose rippling was absent due to the 
synchronous interplay condition (β = integer = 5) between the couch motion and 
longitudinal target motion.  The dose rippling-like feature present inside the PTV region 
for the measured “no motion” dose profile was attributed to the oval shape of the body 
phantom (width = 30 cm, height = 20 cm), which yielded a different attenuation path 
length as a function of gantry angle.  A difference of 2.5 % was observed between the 
                                                 
6
 Dose rounding is manifested as dose blurring in the direction of tumour motion, occurring near the 
longitudinal boundaries of the target volume 
7
 Thread effect is an off-axis beam junctioning effect inherent to helical tomotherapy, which arises mainly 
due to beam divergence.   Please refer to Section 3.3.1, 5.2.2.1, 5.3.2, and 5.4.3 for further explanations. 
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maximum and minimum dose values of this dose rippling-like feature for the “no 
motion” dose profile, while the difference was reduced to 1.5 % for the “motion” dose 
profile.  The decrease in the dose difference was attributed to the “blurring” effect, 
caused by the target motion along the longitudinal direction.  The measured dose profile 
exhibited a dose uncertainty of +0.5 %, calculated as the mean of standard deviations of 
the dose values from the five re-aligned “no motion” profiles acquired under the same 
delivery conditions.  The simulated dose profile agreed with the measured dose profile 
within a standard deviation of 0.5 % inside the PTV region.  
The magnitude of dose rounding was quantified by the penumbral size, which was 
calculated as the average of the distance between the 20 % and 80 % dose points (P20/80) 
and the distance between the 80 % and 20 % dose points (P80/20).  The simulated data 
were generated for the different amplitudes of target motion, while using the same 
treatment parameters and target motion period (Tr).  The plotted data in Figure 2.5 c) 
showed that the penumbral widening worsened with increasing amplitude (A) of target 
motion.  At the target motion amplitude of 1.0 cm, the penumbra size started to increase 
linearly with the target motion amplitude for both target motion periods.  The smaller 
penumbral size was observed for the target motion period of 8 s (Tr = 8 s), as the 
presence of dose ripples inside the PTV (Figure 2.6 b) led to the sharpening of the 
penumbra.8  All the experimental data points agreed with the simulated data points within 
1 mm. 
                                                 
8
 Dose rippling (Section 2.3.1.2) inside the target is manifested as dose undulations along the dose ramp-up 
and ramp-down regions, which may increase or decrease the penumbral size, depending on the phase of 
tumour motion.  In the absence of dose rippling, however, longer tumour motion period (Tr) will always 
lead to an increase in penumbral size. 
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Figure 2.5: (a) Measured film dose distributions on the central coronal plane for a 
non-IMRT helical tomotherapy (p = 8, Tg = 16 s, R = 4) of a central target: in the (i) 
absence and (ii) presence of target motion (Tr = 4 s, A = 1.0 cm, β = 5).  (i) “no 
motion” dose distribution, (ii) “motion” dose distribution (Tr = 4 s, A = 1.0 cm, β = 
5), and (iii) dose difference map between (i) and (ii).  The dotted lines represent the 
axis of gantry rotation (x = 0 cm).  (b) Normalized longitudinal dose profiles along 
the axis of gantry rotation for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R 
= 4) of a central target (Tr = 4 s, A = 1.0 cm).  P20/80 is the distance between the 20 % 
and 80 % dose points, used to quantify penumbral size.  (c) Penumbral size vs. 
amplitude of target motion for two different target motion periods (Tr = 4 s and 8 s) 
for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target.  
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2.3.1.2 Dose Rippling Effect 
In Figure 2.6 a), dose rippling effect was illustrated in the measured coronal dose 
distribution of a non-IMRT helical tomotherapy delivery.  In the “motion” dose 
distribution (ii), the asynchronous interplay condition generated between the couch 
motion and target motion yielded a dose rippling pattern inside the PTV along the 
longitudinal direction (y).  The thread artifact present in the “no motion” dose distribution 
(i) was effectively absent in the “motion” dose distribution, as the larger peak-to-peak 
motion (2A) of 3.0 cm compared to the peak-to-peak motion of 2.0 cm in  Figure 2.5 a), 
leads to an increased “blurring” of dose ripples, and the resulting absence of thread 
artifact.  In the dose difference map (iii), the presence of both dose rippling and dose 
rounding effects are apparent.  Dose profiles along the axis of gantry rotation (dotted line, 
x = 0 cm) were generated from the dose distributions (i) and (ii) to further study dose 
rippling effect. 
As shown in Figure 2.6 b), both dose rounding and dose rippling were observed for the 
measured and simulated dose profiles.  Significant dose rounding occurred due to the 
very large peak-to-peak amplitude of target motion (2A = 3.0 cm).  The asynchronous 
interplay condition (β ≠ integer = 2.5) produced a dose rippling pattern with the dose 
variation of 3.0 %.  The dose variation was measured as the difference between the 
lowest dose valley and the highest dose peak found inside the PTV region.  The simulated 
dose profile agreed with the measured dose profile within a standard deviation of 0.5 % 
inside the PTV region.   
As shown in Figure 2.6 c), the dose profiles were generated by the simulation program 
for different combinations of pitch factor (p) and gantry rotation period (Tg), while 
keeping the β value at 2.5.  The target motion period (Tr) was fixed at 8 s.  The 
magnitude of dose ripples remained at ~2.5 % for all cases, demonstrating that the dose 
rippling effect is independent of the individual parameters governing the β value.9  The 
                                                 
9
 Although the effect of varying the tumour motion period was not presented here, the magnitude of dose 
ripples remains comparable for the same β value acquired with different Tr values. 
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effect of target motion amplitude (A) on the magnitude of dose ripples was also 
investigated using the simulation results.  In Figure 2.6 d), the dose variations are plotted 
as a function of target motion amplitude for a fixed β value of 2.5.  The dose variation 
plot exhibits a sinusoidal-like pattern with the peak of each cycle decreasing with the 
target motion amplitude.  This particular pattern is rather non-intuitive as the largest dose 
variation of 8 % is observed at a relatively small target motion amplitude of 0.30 cm. 
In the initial rise (0 < A < 0.3 cm), the dose variation increases with the target motion 
amplitude (A), due to the respective increase and decrease of the maximum and minimum 
dose inside the PTV.  The maximum dose is received by the PTV points that move into 
the beam both at the start and end of their irradiations, thus increasing the overall 
exposure time compared to the static case.  On the other hand, the minimum dose points 
recede away from the beam at the start and move past the beam near the end of their 
irradiations, resulting in the decrease of the overall radiation exposure time.  When the 
target motion increases beyond A = 0.3 cm, the maximum dose points start to spend time 
outside the beam during their irradiations, with the duration of time outside the beam 
increasing with the target motion amplitude.  The decrease in the maximum dose is then 
compensated by the minimum dose points spending additional time inside the beam.  As 
a result, the dose variation starts to decrease with the amplitude of target motion (0.3 < A 
< 0.6 cm).   
The respective decrease and increase of the maximum and minimum dose continue, until 
the dose received by the “old” minimum dose points surpasses the dose received the 
“old” maximum dose points, thus leading to switches between the positions of the 
maximum and minimum dose points.  The same trend previously observed in the initial 
rise (0 < A < 0.3 cm) is then repeated for 0.6 < A < 0.85 cm, explaining the periodic 
nature of the dose variation pattern.  The dose variation peaks at the different amplitudes 
(A = 0.3, 0.85, 1.35, and 1.85 cm) decrease with the amplitude of target motion, as the 
maximum dose points move out of the beam more frequently during their irradiations 
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with increasing target motion amplitude, thus reducing the maximum exposure time and 
the corresponding dose variation.10  
In Figure 2.6 e), the dose rippling magnitude was plotted as a function of dose rippling 
parameter (β) for the different target motion amplitudes, exhibiting patterns similar to 
“sinc” functions.  “Nodes” were observed at all the integer β values, as dose rippling 
becomes absent at these values.  The dose rippling magnitude does not change 
monotonically with the target motion amplitude, but rather changes up and down in a 
sinusoidal-like manner related to the pattern illustrated in Figure 2.6 d).  The dose 
rippling magnitude declined rapidly with increasing value of dose rippling parameter (β), 
approaching less than 1 % at the β value of 4.5 for all the target motion amplitudes.11  
The largest dose rippling magnitude of ~25 % was observed for the target motion 
amplitude of 0.5 cm and the β value of 1.5, where the target motion period (Tr) 
approached an unusually high value of 10 s.  Dose rippling parameter values lower than 
one (β < 1) were not applicable to helical tomotherapy, and thus were not investigated in 
this study.  For the sliding window technique, however, higher velocities of the jaw 
motion (compared to the couch motion) lead to faster radiation beam movements than 
helical tomotherapy, which in turn yield lower the dose rippling parameter values.  In the 
study by Yu et al [18], the employed jaw motion velocities produced β values ranging 
from 0.035 to 1.  The dose rippling magnitude approached as high as 400 % for β values 
close to 0.1. 
                                                 
10
 The maximum dose points moving out of the beam more frequently simultaneously translates into the 
minimum dose points moving into the beam more frequently, overall reducing the dose variation. 
11
 A non-integer β value indicates the presence of an incomplete tumour motion cycle during the time for 
the treatment couch to advance by one fan beam thickness (Tg / p).  The incomplete portion of a tumour 
cycle leads to the different points within the target to experience different radiation exposure time. With 
increasing β value, the absolute time of this incomplete portion decreases, thus reducing the variation in 
radiation exposure time between different points, which in turn leads to a reduction in dose rippling 
magnitude. 
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Figure 2.6: (a) Measured film dose distributions on the central coronal plane for a 
non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target: (i) “no 
motion” dose distribution, (ii) “motion” dose distribution (Tr = 8 s, A = 1.5 cm, β = 
2.5), and (iii) dose difference map between (i) and (ii).  The dotted lines represent the 
axis of gantry rotation (x = 0 cm).  (b) Normalized longitudinal dose profiles along 
the axis of gantry rotation for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R 
= 4) of a central target (Tr = 8 s, A = 1.5 cm, β = 2.5).  The dose variation was 
measured as the difference between the lowest dose valley and the highest dose peak 
found inside the PTV region.  (c) Simulated longitudinal dose profiles along the axis 
of gantry rotation for a non-IMRT helical tomotherapy of a central target (Tr = 8 s, 
A = 1.5 cm, β = 2.5).  Four different dose profiles were generated using different 
combinations of pitch factor (p) and gantry rotation period (Tg), while keeping the β 
value at 2.5.  (d) Simulation study: Dose variation vs. target motion amplitude (Tr = 
8 s) for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, R = 4) of a central target 
under the asynchronous interplay condition (β ≠ integer = 2.5).  (e) Simulation 
study: Dose rippling magnitude vs. dose rippling parameter (β) for different 
amplitudes of target motion for a non-IMRT helical tomotherapy (p = 0.8, Tg = 16 s, 
R = 4) of a central target.  
64 
 
2.3.2 IMRT Helical Tomotherapy Case 
As shown In Figure 2.7 a), simulated longitudinal dose profiles were generated for the 
different values of target motion periods for an IMRT helical tomotherapy delivery.  The 
unusually large target motion period of 15 s yielded a dose rippling pattern inside the 
PTV with a magnitude of 2.0 % (β ~ 3.5).  Meanwhile, the dose profile resulting from the 
target motion period of 4 s showed little differences from the “no motion” dose profile.  
While no major dose discrepancies were observed for Tr = 15 s and 4 s, one couldn’t 
interpolate or predict the major dose perturbations at Tr = 8 s , based on the results from 
the other target motion periods.  The IMRT leaf opening synchronization effect was 
observed, producing the largest dose discrepancies of 11.3 %12 for the motion amplitude 
of 0.3 cm.  Further investigations with other target motion periods (not presented here) 
showed that the IMRT leaf opening asynchronization effect was plan-specific.  The 
artifact was present at a wider range of tumour motion periods than the dose rippling 
effect, with the largest dose discrepancies observed at a particular target motion period, 8 
s for the particular IMRT helical tomotherapy case investigated in this study. 
In Figure 2.7 b), the effect of target motion is illustrated in the coronal dose distribution 
of an IMRT helical tomotherapy delivery for a target motion period of 8 s.  The dose 
difference map (iii) between the planned (“no motion”) and delivered (“motion”) dose 
distributions demonstrated significant motion-induced dose errors.  The longitudinal dose 
profiles were then obtained along the axis of gantry rotation for the “no motion” and 
“motion” dose distributions to further examine the different dose discrepancies present.  
In Figure 2.7 c), the measured and simulated dose profiles exhibited IMRT leaf opening 
asynchronization effect and dose rounding effect.  The IMRT leaf opening 
asynchronization effect was observed inside the PTV region, where the difference 
between the measured “motion” and “no motion” dose profiles ranged from -29 % to 7 
%.  The asynchronous interplay between the temporal patterns of leaf openings and target 
                                                 
12
 The dose discrepancy of 11.3% was calculated as the total variation in dose differences between the 
planned and delivered dose profiles inside the target, which ranged from -6.1 to 5.2% for tumour motion 
period (Tr) of 8 s. 
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motion is the cause of this effect.  The simulated dose profile agreed with the measured 
dose profile within a standard deviation of 1.7 % inside the PTV region.   
Significant dose rounding was also observed near the PTV boundaries due to the very 
large peak-to-peak amplitude of target motion (2A = 3.0 cm).  However, dose rippling 
was not observed despite the asynchronous interplay condition (β ≠ integer ~ 6.5), as the 
use of a tighter pitch factor (p = 0.287) compared to the non-IMRT cases (p = 0.8) 
yielded a much higher non-integer β value (β ~ 6.5 versus β = 2.5).  It was previously 
shown in Figure 2.6 c) that the dose rippling magnitude started to become insignificant at 
β = 4.5 for all the target motion amplitudes, thus explaining the absence of dose rippling 
at β ~ 6.5.  Dose rippling was also not observed in the study by Kanagaki et al [20], 
where a pitch factor of 0.3 was assigned for all the IMRT helical tomotherapy cases, 
yielding high β values varying from 10 to ~67.  Therefore, dose rippling should not be a 
concern clinically, unless the breathing patterns exhibit unusually lengthy tumour motion 
periods (Tr).  In the clinical setting, pitch factors (p) of less than 0.3 are typically used 
along with the gantry rotation periods (Tg) ranging from 15 to 20 s, likely driving the β 
values well above 4.5.   
The characteristics of the IMRT leaf opening asynchronization effect were further 
investigated by studying its relationship with the target motion amplitude, and also the 
effect of having multiple fractions.  In Figure 2.7 d), underdosing of the PTV and dose 
rounding both worsened with increase in the target motion amplitude, while the PTV 
overdosing was significantly reduced for the amplitude of 2.0 cm.  In Figure 2.7 e), the 
effect of delivering multiple dose fractions on the IMRT leaf opening asynchronization 
effect was investigated by introducing a random starting phase of target motion for each 
fraction for the total of 30 fractions. The resulting dose profiles were then summed up to 
generate a single composite profile.  When compared to the “no motion” profile, the 
“random phase” dose profile exhibited significant dose differences ranging from -16.5 % 
to 1.5 %.  The “random phase” dose profile was also quite symmetrical in shape.  This 
was attributed to the fact that most of the 30 randomly generated dose profiles had dose 
profiles that were roughly mirror images of themselves.  In Figure 2.7 e), the dose 
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profiles with the starting phases of 00 and 1800 were essentially the mirror images of each 
other.13 
 
 
                                                 
13
 The dose profiles with the starting phases of 00 and 1800 were identical to their corresponding single-
fraction dose profiles. 
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Figure 2.7: (a) Simulated longitudinal dose profiles along the axis of gantry rotation 
for an IMRT helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (A 
= 0.3 cm) for different target motion periods (Tr).  (b) Measured film dose 
distributions on the central coronal plane for an IMRT helical tomotherapy (p = 
0.287, Tg = 15 s) of an off-axis target: (i) “no motion” dose distribution, (ii) “motion” 
dose distribution (Tr = 8 s, A = 1.5 cm), and (iii) dose difference map between (i) and 
(ii).  The dotted lines represent the axis of gantry rotation (x = 0 cm).  (c) 
Normalized longitudinal dose profiles along the axis of gantry rotation for an IMRT 
helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (Tr = 8 s, A = 1.5 
cm).  (d) Simulated longitudinal dose profiles along the axis of gantry rotation for an 
IMRT helical tomotherapy (p = 0.287, Tg = 15 s, R = 8) of an off-axis target (Tr = 8 s) 
for different target motion amplitudes (A).  (e) Simulated longitudinal dose profiles 
along the axis of gantry rotation for an IMRT helical tomotherapy (p = 0.287, Tg = 
15 s, R = 8) of an off-axis target (Tr = 8 s, A = 1.5 cm) for 30 fractions.   
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2.3.3 Potential Solutions for Minimization of the Three Dose 
Discrepancies 
Various approaches have been proposed to minimize the effect of tumour motion during 
helical tomotherapy [4,11-13].  Increasing the PTV margin size along the direction of 
target motion is the simplest way to compensate for the dose rounding effect, at the 
expense of increasing the integral dose to the patient.  In Figure 2.5 c), the penumbral 
widening due to dose rounding was shown to be proportional to the target motion 
amplitude (A), thus making the PTV margin size directly dependent upon the target 
motion amplitude.  However, the dose rippling and IMRT leaf opening asynchronization 
effects cannot be resolved by this approach alone, as the asynchronous interplay 
conditions still remain.  The effects of all three dose artifacts could be minimized 
effectively by immobilizing the target volume only during the “beam ON” time through 
breath-holding [11,13].  However, breath-holding may not be feasible physically for all 
lung cancer patients, due to their compromised lung functions.  In the “motion-
incorporated helical tomotherapy”, the tumour motion information acquired prior to the 
treatment is utilized during the plan optimization process [12,26].  As a result, the tumour 
motion is accounted for during the treatment, while the patient is still allowed to breathe 
normally.  This method, however, requires the patient to reproduce the identical breathing 
pattern used for planning during the treatment, which may not be guaranteed in practice.  
Failure to reproduce the same breathing pattern can result in significant dose 
discrepancies between the planned and delivered dose distributions.   
Respiratory gating can be incorporated into helical tomotherapy in the form of the “multi-
pass respiratory gating technique” [27], without placing any constraints on the patient 
breathing.  Due to the continuous motion of the treatment couch, multiple passes of 
helical tomotherapy deliveries are required to complete the helical tomotherapy plan, 
instead of the conventional single pass.  During each pass, only the beam projections 
overlapping with the gating windows are delivered, while the remaining beam projections 
are “blocked” by the complete closure of all 64 binary MLC leaves.  After each pass, the 
couch is reset to its starting position, and the treatment commences at a different phase of 
tumor motion for the gating windows to cover the previously undelivered beam 
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projections.  This process is repeated until all of the planned beam projections are 
delivered.  Respiratory gating reduces the magnitude of target travel during the “beam 
ON” time, leading to the decrease in both the penumbral size and the PTV margin size 
required to compensate for dose rounding.  Respiratory gating also alters the periodicity 
of the target motion during the “beam ON” time.  Thus, the asynchronous conditions 
existing for the dose rippling and IMRT leaf opening asynchronization effects can be 
altered into the synchronous conditions, resulting in the minimization of both effects.  
The disadvantages of respiratory gating include the escalations in the treatment time and 
the patient integral dose, resulting from the multiple passes.  The feasibility of this 
approach continues to be investigated in our laboratory.  In the “real-time motion-
adaptive delivery” [4], the beam projections of a planned leaf opening sinogram are 
delivered out of order (“shuffled”) according to the tumour motion, rather than 
sequentially.  This means that in place of each planned beam projection, a past or future 
beam projection corresponding to the position of the tumour volume at a given time is 
selected and delivered.  This particular method also places no constraints on the patient 
breathing.  Each of the proposed techniques relies on various assumptions about the 
nature of tumour motion, and offers advantages and disadvantages for the helical 
tomotherapy treatment of a moving target.         
2.4 Conclusions 
In this study, three different dose discrepancies arising from the presence longitudinal 
tumour motion during helical tomotherapy were identified.  Their characteristics were 
investigated through both computer simulation modeling and experimental verification 
using a motion phantom with film.  The characteristics of the three different motion-
induced dose discrepancies were illustrated, and the dosimetric significance of each effect 
was described.  The computer simulation model was shown to be a valuable tool for 
predicting the dosimetric impact of target motion during helical tomotherapy, as the 
calculated dose profiles agreed with the measured data within +0.5 % and +1.5 % inside 
the PTV region for the non-IMRT and IMRT tomotherapy deliveries, respectively.  
Various potential solutions to minimize the effect of target motion were also discussed, 
and each proposed method needs to be investigated for its effectiveness in suppressing 
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the three dose discrepancies described here.  The computer simulation model could also 
prove useful during the patient selection process for the different approaches of 
minimizing dose artifacts. 
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Chapter 3  
3 Investigation of Dose Homogeneity for Loose Helical 
Tomotherapy Delivery in the Context of Breath-Hold 
Radiation Therapy 
The work in this chapter is based on a publication, “Kim B, Kron T, Battista J, and Van 
Dyk J (2005) Investigation of dose homogeneity for loose helical tomotherapy delivery in 
the context of breath-hold radiation therapy. Phys Med Biol 50, 2387-404.” 
http://dx.doi.org/10.1088/0031-9155/50/10/014 
3.1 Introduction 
3.1.1 Helical Tomotherapy 
In helical tomotherapy (HT) [1,2], an intensity-modulated fan beam of radiation is 
delivered to the patient in a helical manner, as a result of gantry rotation occurring 
simultaneously with linear couch motion (Figure 3.1).  Each gantry rotation is divided 
into 51 equally-spaced beam projections with each projection spanning over ~7°.  Beam 
modulation is facilitated by a binary multi-leaf collimator (b-MLC) consisting of 64 
leaves.  Overall, these features provide tomotherapy with the ability to sculpt a highly 
conformal dose distribution.  The gantry rotation period (Tg) can be set between 10 s and 
60 s, depending on the dose that needs to be delivered per rotation.  In the standard 
tomotherapy practice, the couch advances by less than the fan beam thickness during 
each gantry rotation (i.e. pitch factor < 1), in order to avoid problems of abutment regions 
which may occur in serial tomotherapy [3].  Pitch factor (p) is defined as the amount of 
couch translation that occurs during one gantry rotation, divided by the fan beam 
thickness (b).  Fan beam thickness (b) is the defined as the distance between the 50% of 
the maximum dose value along the axis of gantry rotation in the direction of couch 
translation.  Other tomotherapy parameters include the number of beam projections per 
gantry rotation (n), and number of gantry rotations (R) required to cover the entire target 
length along the direction of couch motion. 
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Figure 3.1: Helical tomotherapy (HT): The helical line depicts the path of beam 
projections (stars) during a tomotherapy treatment.  The Y-axis indicates the 
direction of couch motion.  HT-specific parameters include fan beam thickness (b), 
number of beam projections per gantry rotation (n), and number of gantry 
rotations (R) required to cover the entire target.  The distance travelled during one 
gantry rotation is determined as the product of fan beam thickness and pitch factor 
(b x p).  
3.1.2 Target Motion 
Respiration-driven target motion is a major problem in radiation therapy of lower lobe 
lung cancer, as larger target margins are required to compensate for the target’s range of 
motion, which may reach up to several cm’s [4-6].  As a result, a significant volume of 
healthy lung tissues is exposed to radiation, which in turn limits the maximum dose that 
can be delivered to the tumour.  Thus, it is crucial to address target motion in order to 
take full advantage of highly conformal dose delivery provided by HT.  Four motion 
mitigation methods are currently available for conventional radiation therapy and IMRT 
(Table 3.1).  Of these choices, breath-holding appears to be the easiest one to implement 
for HT.  Other techniques would require a complex control mechanism to co-ordinate the 
movement of the three HT subsystems (gantry, b-MLC, and couch) with respect to the 
target motion.  In contrast, breath-holding requires no such effort as the target motion is 
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significantly reduced within the treatment field during radiation delivery.  Breath-holding 
also allows one to choose the phase within the breathing cycle, which is most ideal for an 
effective treatment.  Thus, we propose a different HT approach, namely loose helical 
delivery, which is ideally suited for breath-hold HT.  Although loose helical delivery has 
been suggested [15], it has never been fully studied or described in the literature.  In the 
present study, the dosimetric characteristics of loose helical delivery are investigated in 
comparison to standard HT.  Standard HT (p < 1) is referred to as tight helical delivery 
throughout this paper.  Different HT cases have been simulated in the treatment planning 
software and then verified experimentally with film. 
Table 3.1: Motion mitigation methods. 
 
3.1.3 Loose Helical Delivery 
Loose helical delivery consists of a number (H) of individual interlaced “loose” helices 
commencing at different gantry angles.  The starting gantry angles are equally divided 
around the gantry, while the same starting couch position is assigned to all loose helices 
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(Figure 3.2).  Each loose helix covers the entire target length in a single gantry rotation (R 
= 1) by utilizing a pitch factor of greater than 1 (p > 1), during which breathing-holding 
takes place.  This way no interruptions are required during beam delivery except for cases 
such as coughing where the target accidentally moves out of the treatment field.   The 
gantry rotation period (Tg) should be set to the minimum allowed time of 10 s in order to 
maximize the number of patients who can tolerate this approach.  After the completion of 
each loose helix, the couch travels back to its starting position for the next loose helix to 
begin.  It is during the time slots between the helices when the patient is allowed to 
breathe normally.  The required pitch factor for loose helical delivery is calculated by 
Equation 3.2, which is derived from Equation 3.1.  It is directly dependent on the length 
of target (L) along the axis of gantry rotation and the fan beam thickness (b):      
 
pb
bL
factorpitchthicknessbeamfan
thicknessbeamfanlengthetargt
neededrotationsofR
⋅
+
=
×
+
== #  (3.1)  
 
b
bLp
pb
bLR
deliveryhelicallooseforTherefore
+
=⇒
⋅
+
== 1
:,
 (3.2) 
 
Figure 3.2: Loose helical delivery: each loose helix (p > 1) with a different starting 
gantry angle covers the entire target in one gantry rotation (R = 1), during which 
breath-holding takes place.  Required pitch factor is dependent on target length and 
fan beam thickness.  In this example, loose helical delivery consists of four helices (H 
= 4). 
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3.2 Materials and Methods 
HT treatments were simulated in the conventional linear accelerator environment, since 
the current HT planning software does not allow for the optimization of loose helical 
delivery.  The HT beam was represented by the 6 MV x-ray beam from a conventional 
linear accelerator (Varian Clinac 2100 C/D) collimated to a fan beam geometry.  The 
normalized photon spectrum of a HT beam is comparable to that of the 6MV Varian 
Clinac beam with the similar maximum photon energy of 6 MV, although the peak of the 
energy spectrum shifts from 0.4 MeV to 0.5 MeV for the HT beam [16].  The absence of 
the flattening filter and the shorter source-to-axis distance (85 cm versus 100 cm) of the 
HT machine (TomoTherapy Inc., Madison, WI) were not modelled in this study.  As a 
result, the 6MV beam used in this study has a slightly different TPR 20/1014 value of 0.67 
compared to the TPR 20/10 value of 0.63 for the HT beam. 
During a HT delivery, each gantry rotation is equally divided into 51 beam projections by 
momentary closing of all leaves between the beam projections.  Radiation delivery 
remains continuous over the span of each beam projection.  In study, however, the 
individual beam projections were depicted as “snap-shots” of radiation occurring at 
different gantry angles.  Each beam projection was modelled as an open beam with no 
beam intensity modulation.  In order to mimic the continuous couch motion of a HT 
machine, each beam projection was assigned a unique couch position.  The displacement 
between beam projections, termed here as “projection increment” was calculated as 
follows: 
 
n
bp
rotationgantrypersprojectionbeamof
rotationgantryperntranslatiocouchincrementprojection ⋅==
#
 (3.3) 
In the present study, both loose and tight helical deliveries with limited numbers of beam 
projections (i.e. less than 51) were chosen to investigate the dosimetric impact of the 
tomotherapy parameters.  The different HT cases studied are summarized in Table 3.2.  A 
                                                 
14
 Tissue-phantom ratio (TPR) is the ratio of the dose at a given point in phantom to the dose at the same 
point at a reference depth for the same field size.  TPR 20/10 is the TPR ratio at depths of 20 cm and 10 cm 
in water.   
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fan beam thickness of 4.5 cm (Y) and a fan beam width of 10 cm (X) were selected to 
treat an arbitrary cylindrical target (10 cm in diameter, 4.5 cm (Y) in length) inside a 
cylindrical phantom with a diameter of 20 cm (Lucite, ρ = 1.18 g/cm3).  Central axes of 
both the target and the phantom were aligned to the axis of gantry rotation of the linear 
accelerator. 
Table 3.2: Tomotherapy scenarios.15 
 
3.2.1 Computer Simulations 
The HT cases summarized in Table 3.2 were planned with Theraplan Plus (TPP) v.3.0 
software (MDS Nordion, Kanata, Canada).  The treatment planning software uses a 
pencil-beam algorithm, and the equivalent tissue-air ratio (TAR) method [17] including 
electron transport [18] for inhomogeneity corrections when using photon beams.  The 6 
MV photon beam model was specifically commissioned for the fan beam dimension (10 
cm (X) x 4.5 cm (Y)) based on film data.16  Film data were obtained for three different 
                                                 
15
 For loose helical delivery, number of loose helices was selected such that the total number of beam 
projections remains the same as tight helical delivery. 
16
 Film data were acquired to provide depth dose profile information for different field size. 
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square field sizes (4.5 cm, 6.2 cm, and 10 cm) at five different depths (0.5 cm, 1.5 cm, 3 
cm, 5 cm and 10 cm), as TPP only allows square field data for beam modelling [19].   
Instead of using the CT images of the actual phantom where a slice spacing (Y) of 3 mm 
would be used, a virtual phantom was created within TPP to produce a finer slice spacing 
of 1 mm (Y), thus allowing dose calculation at that interval.  A relative electron density 
of 1.146 [20] was assigned to the whole phantom to represent Lucite (ρ = 1.18 g cm-3).  
All dose calculations were performed using a pencil beam size of 1 mm with 
inhomogeneity corrections.  The dose calculation grid spacing of 1 mm was used along 
all axes (X, Y, Z).  Dose profiles were obtained along X = 0 cm, +2 cm, +4 cm axes on 
the calculated dose distribution plane (Z = 0 cm) bisecting the target.   
The calculated dose distributions were normalized to the sum of beam weights, each of 
which represented the dose at the isocentre.  Percentage dose values were then re-
normalized to the average dose along the central section (3.9 cm) along the axis of gantry 
rotation.  The length of 3.9 cm was determined by subtracting 3 mm from each side of the 
target length (4.5 cm) to account for the rounding of dose profile. 
3.2.2 Experimental Verification 
Experiments were carried out on the linear accelerator to verify the dose distributions 
calculated by Theraplan Plus.  Each experiment was performed with a film placed inside 
the cylindrical phantom (Lucite, ρ = 1.18 g/cm3, 20 cm in diameter and length), which is 
shown in Figure 3.3.  Kodak EDR2 film was chosen for the relatively large linear dose 
response range of 25-400 cGy [21-24].  A 10” x 12” film was cut in half and placed 
inside the film cassette of the phantom.  The film cassette is made of black-coloured 
Lucite (ρ = 1.18 g/cm3) in order to prevent light from reaching the film.  Inside the film 
cassette, two film pieces are separated by a 6 mm film divider to provide dose 
distribution results for two planes (Z = 0 cm and Z = -0.6 cm).  However, only the 
outcomes for Z = 0 cm plane are presented in this study.  Three trials were performed for 
Case 1 of loose helical delivery (n = 5) to determine the reproducibility of the 
experiment.  
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Figure 3.3: Cylindrical Lucite (ρ = 1.18 g cm-3) phantom 
The number of monitor units (MU) delivered per beam projection is calculated so that the 
total number of monitor units remains approximately the same for all cases: 
 ttanconsMURn ≈××   
After each beam projection, the couch was unlocked and manually translated to the next 
couch position, according to the projection increment calculated using Equation 3.3.  
Rulers taped on both sides of the phantom were used to verify the position of the 
phantom with the cross-sectional laser.  Each film was scanned and analyzed using film 
dosimetry system software (RIT 113 v.3.13).  Dose profiles were obtained along X = 0 
cm, +2 cm, +4 cm axes on the Z = 0 cm coronal plane.  A calibration film was taken on 
each experimental day using an open 6 MV photon beam.  A calibration film was taken 
on each experimental day using an open 6 MV photon beam.  The calibration film was 
exposed at the isocentre with four 4 x 4 cm2 fields with different monitor units (25 MU, 
100 MU, 175 MU, 250 MU) with a 5 cm buildup of solid water. 
3.3 Results 
Both computer simulations and film experiments were used to study the dose 
homogeneity for loose helical delivery compared to standard HT in a cylindrical target.  
Two major effects were observed: the “thread” effect and the “beating” effect.  In this 
section, results defining and characterizing these two effects are presented.   
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3.3.1 “Thread” Effect 
In Figure 3.4, the dose distribution results based on the TPP and the film data are 
presented for the two delivery methods: tight (Case 2, n = 5) and loose helical delivery 
(Case 3, n = 10).  The dose patterns observed in the TPP data are supported by the film 
data.  In Figure 3.4 a) and c), the dose distribution for Case 2 (n = 5) of tight helical 
delivery is characterized by the presence of higher dose regions, occurring away from the 
axis of gantry rotation – known as the “thread” effect [25].  The higher dose regions 
consisted of dose values greater than 100 % and in this case, the maximum dose value 
reached ~105 %.  The positions of these higher dose regions followed a helical path with 
respect to the axis of gantry rotation.  This particular dose pattern due to the thread effect 
was observed in all tight helical delivery cases in this study.  The thread effect was also 
manifested as ripples in the isodose plots of HT plans produced for complex lung cases at 
our institution [26], confirming that the thread effect is indeed an inherent characteristic 
of HT.   
The presence of higher dose regions led to dose modulations in the off-axes dose profiles 
(X = + 2 cm, + 4 cm).  Dose modulation is defined as the peak-to-trough difference in 
percent dose within the target region, while off-axes include all longitudinal axes parallel 
to the axis of gantry rotation, except the axis of gantry rotation.  It was observed the 
magnitude of dose modulations increased away from the axis of gantry rotation, while no 
dose modulations were observed along the axis of gantry rotation (X = 0 cm) for all tight 
helical delivery cases.   
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Figure 3.4: Dose distribution results on the coronal plane Z = 0 cm for: (a) Case 2 (n 
= 5) of tight helical delivery (p = 0.5), Theraplan Plus (TPP).  (b) Case 3 (n = 10) of 
loose helical delivery (p = 2), Theraplan Plus (TPP).  (c) Case 2 (n = 5) of tight 
helical delivery (p = 0.5), film.  (d) Case 3 (n = 10) of loose helical delivery (p = 2), 
film.  The dotted line in each dose distribution represents the axis of gantry rotation 
(X = 0 cm).  The solid arrows in (a) are pointed to the higher dose regions, which are 
spaced by b x p (fan beam thickness times pitch factor).  The white circular annulus 
observed in (d) is an artifact due to the underlying mechanical couch structure. 
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The thread effect and the absence of dose modulations along the axis of gantry rotation 
are due to beam divergence.  It causes the magnitude of fan beam thickness to vary away 
from the axis of gantry rotation.  Along the axis of gantry rotation, the fan beam thickness 
(b) remains the same (i.e. 4.5 cm) at all gantry angles.  However, at the off-axes, the 
magnitude of fan beam thickness (b’) changes as a function of the off-axis position (X) 
and the beam gantry angle (θ) according to: 
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At the off-axes, beam projections with different fan beam thickness lead to peaks and 
troughs in the primary fluence profiles.  In Figure 3.5, the schematic illustration is 
presented for the primary fluence profile along an off-axis, X = 4 cm for Case 2 (n = 5) of 
tight helical delivery.  Each beam projection is represented by a rectangle, whose width 
and height represent fan beam thickness and primary photon fluence, respectively.  The 
main purpose of this schematic illustration was to show the variation in the intensity 
pattern due to beam projection overlaps, as change in fluence according to the distance 
from the source was not modeled.   
The overall pattern of the fluence profile shown in Figure 3.5 supports the dose 
modulation pattern observed in the dose profiles (Figure 3.6) obtained from the TPP and 
the film data.  The fluence profile consists of a set of two troughs and two peaks, 
followed by another set, where each set contributes to a dose peak.  The two sets of 
troughs and peaks in the fluence profile are separated by the same distance as the two 
dose peaks, which is the couch distance travelled during one gantry rotation (b x p).  
 
 
 
                                                 
17
 sinθ = cos(900-θ) 
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Figure 3.5: Schematic fluence profile along the X = 4 cm axis for Case 2 (n = 5) of 
tight helical delivery (p = 0.5). The target (4.5 cm) is treated over 4 gantry rotations 
(R = 4) with a fan beam thickness (b) of 4.5 cm.  Each rotation is comprised of 5 
beam projections with following gantry angles: 0°, 72°, 144°, 216°, 288°.  The fan 
beam thickness (b’) along the X = 4 cm axis changes as a function of gantry angle 
according to Equation 3.4. 
 
Figure 3.6: Dose profile along the X = 4 cm axis for Case 2 (n = 5) of the tight helical 
delivery based on the Therplan Plus (TPP) data, and the film data. 
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Along the axis of gantry rotation inside the cylindrical target, both the fan beam thickness 
and the primary photon fluence remain the same at all gantry angles.  These conditions 
result in a primary fluence profile with homogenous fluence without any modulations 
inside the target region (Figure 3.7).  Homogenous fluence within the target profile in 
turn produces dose profiles exhibiting no dose modulations (Figure 3.8).  The absence of 
dose modulations along the axis of gantry rotation was true for all tight helical delivery 
cases. 
In Figure 3.4 b) and d), higher dose regions are noticeably absent in the dose distribution 
for Case 3 (n = 10) of loose helical delivery.  In Figure 3.9, it is illustrated that along the 
off-axis X = 4 cm, the change in fan beam thickness due to beam divergence is 
counteracted by the presence of multiple beam gantry angles at each couch position.  As a 
result, the off-axes dose modulations inherent in tight helical delivery are eliminated 
(Figure 3.10), and a more homogenous dose distribution is produced, illustrating the 
dosimetric advantage of loose helical delivery. 
In Figure 3.4, the five narrow strips18 observed near the boundaries of high dose region 
(between X = +4 cm and +5 cm) resulted in the maximum dose modulation of 1% and 
2% for TPP and film, respectively.  The strips were separated by a distance equal to the 
projection increment, which was 0.9 cm for this case.  This dosimetric feature is 
attributed to the fact that each beam projection undergoes different amount of attenuation 
before reaching a point along the off-axis.  As a result, a different dose is deposited by 
each beam projection.  As the off-axis position moves away from the axis of gantry 
rotation, the variation in the depth dose of the different beam projections becomes greater 
– thus producing small dose variations observed near the boundaries of the high dose 
region.  The same feature was observed for Case 5 of loose helical delivery (n = 18).  
However, due to the overlaps of the strips (0.5 cm apart), no discernable dose 
modulations were observed from the TPP data, while only a maximum dose modulation 
of 1% was observed from the film data. 
                                                 
18
 The five narrow strips refer to the thin white strips observed near the edges of the high dose region in 
Figure 3.4 (d) for loose helical delivery. 
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Figure 3.7: Schematic fluence profile along the axis of gantry rotation (X = 0 cm) for 
Case 2 (n = 5) of tight helical delivery (p = 0.5).  The target (4.5 cm) is treated over 4 
gantry rotations (R = 4) with a fan beam thickness (b) of 4.5 cm.  Each rotation is 
comprised of 5 beam projections with following gantry angles: 0°, 72°, 144°, 216°, 
288°. 
 
Figure 3.8: Dose profile along the X = 0 cm axis for Case 2 (n = 5) of the tight helical 
delivery based on the Theraplan Plus (TPP) data, and the film data 
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Figure 3.9: Schematic fluence profile along the X = 4 cm axis for Case 3 (n = 10) of 
loose helical delivery (p = 2).  The target (4.5 cm) is treated with 4 interlaced loose 
helices (H = 4).  Each helix is comprised of 10 beam projections (n = 10) with a 
different starting gantry angle (0°, 90°, 180°, 270°).  The off-axis position (X = 4 cm) 
results in different fan beam thickness (b’) at each gantry angle.  Fluence variations 
due to inverse square law and beam attenuation were not modelled. 
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Figure 3.10: Dose profile along the X = 4 cm axis for Case 3 (n = 10) of loose helical 
delivery based on the Theraplan Plus (TPP) data, and the film data 
3.3.2 “Beating” Effect 
The dose homogeneity within a dose distribution by loose helical delivery was affected 
however, when the ratio between the number of beam projections (n) and pitch factor (p) 
was not an integer.  A non-integer n / p value produced unwanted dose modulations along 
all off-axes as well as on the axis of gantry rotation, resulting in the “beating” effect 
(Figure 3.11).  The separation between dose peaks was equal to the projection increment. 
As seen in Figure 3.11 and Table 3.3 (loose helical delivery case), increasing the n / p 
ratio reduced the magnitude of dose modulations. 
The maximum dose modulations for all tight and loose helical deliveries are summarized 
in Table 3.3.  An experimental uncertainty of 2 % (2σ) dose modulation was calculated 
based on the relative standard deviation of the three trials performed for Case 1 of loose 
helical delivery (n = 5).  The dose modulations according to film data were consistently 
higher than the TPP calculations, where an average difference of 3 % was found with 4 % 
being the maximum.  The difference was attributed to the fact that the treatment planning 
software overestimates the tail regions of 6 MV beam profiles for different field sizes and 
depths, thus yielding smaller dose modulations. 
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Figure 3.11: Film results and dose profiles for loose helical delivery of (a) Case 1 (n 
= 5), n / p = 2.5; (b) Case 4 (n = 15), n / p = 7.5.  The dose profiles were taken along 
the dotted line, representing the Y-axis axis. 
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Table 3.3: Maximum dose modulations. 
 
3.4 Discussion 
3.4.1 Comparison of Loose and Tight Helical Delivery 
3.4.1.1 “Thread” Effect 
Tight helical delivery is characterized by the thread effect [25], which results in dose 
modulations away from the axis of gantry rotation.  In this study, the thread effect 
produced dose modulations as high as 14 % inside the target region along the off-axes X 
= +4 cm for n = 3 (Table 3 (tight helical delivery case).  Dose modulations were present 
even at n = 45 according to the TPP data, indicating that the thread effect takes place 
regardless of the number of beam projections.  Thus, dose modulations due to the thread 
effect are expected to be present for the current HT unit (n = 51).  This is indeed 
confirmed by our experience with the unit and its treatment planning software [26].   
The advantage of loose helical delivery lies in its ability to produce a homogeneous dose 
distribution by eliminating thread effect.  This was seen in Case 3 and 5 of loose helical 
delivery, where the absence of higher dose regions resulted in dose profiles with no dose 
modulations.  This is due to the fact that loose helical delivery treats the target with 
helices commencing at different gantry angles.  We expect this advantage to persist also 
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for intensity modulated HT deliveries as long as the different starting angles can be 
included in the plan optimization.   
3.4.1.2 Sensitivity to the Uncertainty of Couch Movement 
The study by Yang et al [27] reported that the HT delivery is much less sensitive to the 
uncertainty in couch position compared to serial tomotherapy [3].  A 1.0 mm error in 
couch position resulted in 5% dose modulations, whereas in serial tomotherapy, dose 
modulations could be as high as 20%.  This is attributed to the difference in the dose 
profiles (in the direction of couch motion) produced by the two techniques after each 
gantry rotation.  The resulting dose profile of the HT delivery after a single gantry 
rotation is triangular in shape containing the “ramp-up” and “ramp-down” regions, in 
contrast to the sharp drop-offs present in the dose profile of a serial tomotherapy beam.  
As a result, the HT delivery can produce a uniform longitudinal dose distribution as long 
as the dose profiles from the different gantry rotations are matched within a few mm, 
while serial tomotherapy requires a more critical matching of the dose profiles. 
For loose helical delivery, each loose helix produces a dose profile that is trapezoidal in 
shape.  There are no junction issues as in the tight helical delivery since the dose profiles 
produced by the individual loose helices are being overlaid onto one another.  At the 
same time, loose helical delivery is more sensitive to systematic uncertainty compared to 
the tight helical delivery, as the same starting couch position must be reproduced multiple 
times.  An uncertainty in the gantry repositioning is also introduced since loose helical 
delivery requires different starting gantry angles for the individual helices.  However, the 
starting couch position is reproducible within an accuracy of 0.5 mm, and thus the impact 
of the starting position uncertainty on the final dose distribution should be negligible.  
The HT unit is capable of repositioning the gantry at the cardinal angles (00, 900, 1800 
and 2700) within 10, and the uncertainty of this magnitude should have minimal effect on 
the dose distribution.  During a HT treatment, the couch position is accurate with +0.5 
mm, and due to the higher couch velocity, loose helical delivery is less sensitive to the 
impact of random uncertainty in the actual couch position compared to tight helical 
delivery.  Thus, overall loose helical delivery should be less sensitive to couch position 
errors. 
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3.4.1.3 “Beating” Effect and its Impact on Pitch Factor Selection 
A non-integer n / p ratio results in the beating effect (first described in this work), which 
creates dose modulations along all X-axes in the direction of couch motion inside the 
target region.   ICRU Reports 50 and 62 recommend the dose given to the planning target 
volume (PTV) to be kept within +7% and -5% of the prescription dose, providing room 
for 12% dose variation [28,29].  In clinical practice, it would be desirable to keep the 
dose variation due to dose modulations under 5% in order to provide room for the other 
sources of uncertainty.  The film data suggest that the dose modulations will remain 
under 5% when the n / p ratio is greater than 7.5.   
With the number of beam projections fixed at 51 for the current tomotherapy unit, most 
loose helical delivery cases will experience dose modulations, since pitch factors other 
than 3 and 17 yield non-integer n / p ratios.  As a result, a restriction must be imposed on 
the maximum allowed pitch factor in order to keep the dose modulations below 5%.  This 
condition in turn places a limit on the maximum treatable target length, which depends 
directly on the pitch factor (p) and the fan beam thickness (b) as shown in Equation 3.2.  
Assuming that the findings in this paper are applicable to the current HT unit, the pitch 
factor must be selected below 7 in order to keep the n / p ratio above 7.5 and the dose 
modulations under 5%.  This in turn limits the maximum treatable target length to 15 cm 
and 30 cm, when using currently available fan beam thickness of 2.5 cm and 5 cm, 
respectively (according to Equation 3.2).  
In the future, improving the current MLC transit time (~30 ms) will increase the number 
of beam projections deliverable per gantry rotation.  As a result, the maximum treat target 
length will become larger as well.  If the option of adjusting the MLC transit speed ever 
becomes available, one would be able to fix the rotation period to the breath-holding 
capability of the patient and select the number of beam projections according to the target 
length.    
In a recent study, HT plans with two different planning target volumes were generated for 
each of ten patients with stage 3 inoperable non-small cell lung cancer [30].  PTV2 was 
created with a 2 cm margin around the gross tumour volume (GTV), while PTV1 
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included regional lymph nodes in addition to the GTV.  The cranial/caudal extensions of 
these PTVs were 12.8 + 4.5 cm for PTV2 and 17.5 + 2.8 cm for PTV1.  Considering the 
ranges of target lengths for these two PTV volumes, loose helical delivery with a fan 
beam thickness of 2.5 cm should be sufficient for most PTV cases containing the lung 
tumour only, while a loose helical delivery plan including elective nodal treatment would 
likely require a fan beam thickness of 5 cm.   
The beating effect was not found to be an issue for the tight helical delivery cases in this 
study, since their n / p ratios were all integers.  Even if they were not integers, dose 
modulations will always be smaller than 5% due to their large n / p values, except for 
Case 1 where n / p is only 6.  For the current tomotherapy unit (n = 51), the beating effect 
will never be a concern for tight helical delivery (p < 1), since the n / p ratio will always 
be larger than 51, which is significantly higher than 7.5.     
3.4.2 Practical Considerations for the Use of Loose Helical 
Delivery 
The additional treatment time required for loose helical delivery arises from the sum of 
couch re-set time between the helices.  Thus, the increase in treatment time directly 
dependent on the number of loose helices (H) used.  Each re-set time is expected to last 
for 30 s provide sufficient recovery time for the next breath-hold.  The re-set time slots 
are represented as the dark bands within the treatment time in Figure 3.12.   
The number of loose helices (H) should be selected such that the total “beam-ON” time 
(H x Tl) required to cover the target is comparable to the total “beam-ON” time (R x Tt) 
for tight helical delivery.  This ensures that the planned dose is delivered to the target 
while performing an equivalent degree of beam intensity modulation.  For loose helical 
delivery, it can be assumed that the gantry rotation period will be set to the minimum 
gantry rotation period of 10 s to account for compromised lung functions of patients.  
Therefore, if the gantry rotation period in tight helical delivery is larger than 10 s, the 
number of required helices (H) needs to be greater than the number of gantry rotations 
(R) used in tight helical delivery.  H is larger than R by the ratio of gantry rotation periods 
used for the two deliveries: 
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where Tl is the gantry rotation period for loose helical delivery and Tt is the gantry 
rotation period for tight helical delivery. 
If one assumes a target length of 10 cm, tight helical delivery using a fan beam thickness 
of 2.5 cm with the recommended pitch factor of 0.3 requires 17 gantry rotations to cover 
a target of this magnitude.   As a typical gantry rotation period ranges from 20 s to 30 s, 
the treatment time should last anywhere from 5 to 10 minutes (Figure 3.12).  In order to 
achieve a similar beam-ON time with loose helical delivery, 34 to 51 loose helices are 
needed.  This yields a total couch re-set time of 15–25 minutes, increasing the total 
treatment time to 20–35 minutes.  However, the treatment time is only a portion of 
session time as shown in Figure 3.12.  Adding the time for set-up and MVCT (20 
minutes) the total session time increases from 25–30 minutes to 40–55 minutes.  This is 
an increase by a factor of ~2, which may be acceptable given the dosimetric advantages 
of loose helical delivery. 
 
Figure 3.12: Total session time for: the tight helical delivery (top), loose helical 
delivery (bottom).  The dark bands within the treatment segment for loose helical 
delivery represent couch re-set time between loose helices, during which the patient 
breathes normally.      
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The overall treatment time may be reduced by utilizing a fan beam thickness of 5 cm, as a 
smaller number of helices will be required.  Olivera et al [31] have shown that the use of 
a larger fan beam thickness yields better dose uniformity.  However, it also compromises 
the ability to perform beam intensity modulation and the accuracy of dose conformation 
to the target in the longitudinal direction.  Therefore, using a fan beam thickness of 5 cm 
would not reduce the number of helices by a factor of 2, but by a factor between 1 and 2.  
At present, the HT treatment planning system does not allow for the planning of loose 
helical delivery.  However, if the loose helical delivery option ever becomes available, 
the time and effort spent for planning and optimization remains the same, since the 
overall number of projections stays the same as in tight helical delivery.  Loose helical 
delivery is also applicable to all tumour targets driven by respiratory motion.  The tumour 
sites may include liver and other sites within in the thoracic cavity. 
3.4.3 Other Methods for Accounting for Respiration-Driven Motion 
in HT 
Table 3.1 gives a summary of all methods, which could be used for mitigation of motion 
in radiation therapy.  In the context of HT, both breath-holding and planning for motion 
prospectively appear to be possible.  In the present study, we have investigated loose 
helical delivery as a potential means to combine breath-holding with improved dose 
distributions.  However, breath-holding may be incorporated into tight helical delivery as 
well.  In the proposed “gating-by-rotation” approach, each rotation of breath-hold 
treatment is followed by a rotation of non-treatment where the patient breathes freely [32].   
During non-treatment rotations, the couch motion is halted and the treatment beam is 
blocked by the closure of all MLC leaves.  This on-off strategy is repeated for the full 
treatment volume.  The dose distribution outcomes of this approach essentially represents 
those of tight helical delivery presented in this study, assuming breath-holding has been 
carried out as planned.   
Recently, the tomotherapy group in Madison, WI has proposed a method that 
incorporates respiratory motion during the optimization process [13,14].  In this 
approach, beamlet calculations are performed at the different phases of the CT data, once 
the correlation between beam delivery and breathing is established.  The calculated 
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beamlets are then mapped back to the primary phase according to the displacement maps, 
and the plan optimization is carried out.  The displacement maps are generated during 
deformable image registrations of the lung at different phases.  However, this method 
only works under the condition that the patient’s breathing can correctly follow the 
breathing guide on the given treatment day. 
3.5 Conclusions 
 Loose helical delivery allows incorporation of breath-holding into helical 
tomotherapy for a more effective treatment of respiration-driven tumour target.    
 The advantage of loose helical delivery lies in its ability to produce a 
homogenous dose distribution by eliminating the “thread” effect – an inherent 
characteristic of tight helical delivery.   
 Loose helical delivery, however, results in the “beating” effect, when the n / p 
ratio is a non-integer.  The magnitude of dose modulations due to the beating 
effect decreases with an increasing n / p ratio.  Thus, a pitch factor must be 
selected such that the magnitude of dose modulations remains below 5 %.   
 The planning effort remains the same for loose helical delivery, and the total 
treatment time increases only by a factor of 2, making loose helical delivery 
clinically practical.  
 Overall, loose helical delivery is promising solution that should be strongly 
considered for the future HT treatments of respiration-driven targets. 
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Chapter 4  
4 Feasibility Study of Multi-Pass Respiratory-Gated 
Helical Tomotherapy of a Moving Target via binary MLC 
Closure 
The work in this chapter is based on a publication, “Kim B, Chen J, Kron T, and Battista 
J (2010) Feasibility study of multi-pass respiratory-gated helical tomotherapy of a 
moving target via binary MLC closure. Phys Med Biol 55, 6673-94.” 
http://dx.doi.org/10.1088/0031-9155/55/22/006 
4.1 Introduction 
Helical tomotherapy [1,2] utilizes a continuously rotating gantry and a linearly moving 
couch to deliver an intensity-modulated fan beam of radiation in a helical manner.  
Helical tomotherapy has been used extensively in the clinics, due to its IMRT dose 
delivery capability combined with the on-line megavoltage CT available for image 
guidance.  Intensity modulation is performed by the binary multi-leaf collimator (b-
MLC), consisting of 64 interlaced binary leaves that either move into or out of the fan 
beam field.  The radiation fluence is then determined by the duration of leaf openings for 
each of the 51 equally-spaced beam projections per gantry rotation.  However, the fan 
beam geometry and the movements of the three subsystems (gantry, couch, and 
collimator) also make helical tomotherapy more susceptible to producing dose artifacts in 
the presence of target motion [3-7].   
Three major motion-induced dose discrepancies have been defined previously for helical 
tomotherapy; (1) dose rounding, (2) dose rippling, and (3) IMRT leaf opening 
asynchronization effect [7].  Dose rounding [3,6,7] is the penumbral widening of a 
delivered dose distribution along the direction of tumour motion.  Dose rippling [3-5,7] is 
a series of periodic dose undulations inside the target volume along the direction of couch 
motion, due to an asynchronous interplay between the couch motion and tumour motion.  
The IMRT leaf opening asynchronization effect [7] is caused by an asynchronous 
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interplay between the temporal leaf opening patterns of the b-MLC leaves and tumour 
motion, yielding a dose discrepancy pattern unique to each tomotherapy plan. 
In the past, various approaches have been proposed to compensate for tumour motion 
during radiotherapy, in the form of breath-holding [8-10], respiratory gating [11-13], and 
tumour-tracking [14,15].  Breath-holding may be incorporated to minimize tumour 
motion during helical tomotherapy, although breath-holding may not be feasible for all 
lung cancer patients due to their compromised lung functions [16,17].  Alternatively, the 
tumour motion information acquired prior to the treatment may be included during the 
plan optimization to allow normal breathing during the actual treatment [18,19].  
However, this method assumes that patients can reproduce the breathing patterns used for 
planning during treatments.  Failure to reproduce the same breathing patterns can lead to 
significant dose discrepancies.  Real-time motion-adaptive delivery [20,21] was proposed 
recently, where the sequence of planned beam projections is “shuffled” and executed out-
of-order according to the tumour motion, thus placing no constraints on patient breathing 
patterns.  The desired dose distributions, however, may not always be achieved, as this 
method does not account for the radiological pathlength differences between the original 
and shifted beam projections.  The spatially shifted beam projections may encounter 
different tissue thicknesses and densities, thus affecting the beam attenuation – especially 
for large amplitudes of target motion.   
We propose a new way to implement respiratory gating for helical tomotherapy, namely 
multi-pass respiratory gating [22].  In this approach, the tumour motion during the 
radiation delivery is restricted to the residual motion within the gating window.  Thus, 
this method reduces the beam attenuation differences caused by the relative motion 
between the tumour volume and the surrounding normal tissues.  Due to the continuous 
couch motion during helical tomotherapy, the planned beam projections must be 
delivered over multiples passes of radiation deliveries.  The multiple passes may consist 
of all gated passes (“full gating”) or multiple gated passes and one final ungated pass 
(“partial gating”).  In the present study, we investigated the feasibility and effectiveness 
of the proposed technique for sinusoidal motion (“ideal” scenario) and a patient 
respiratory motion pattern (“realistic” scenario).  Full gating was tested for sinusoidal 
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motion, through experimental measurements with film and computer simulation for a 
single fraction.  For the patient waveform, both full and partial gating methods were 
investigated for various fractionation schemes (1, 3 and 30 fractions), through computer 
simulation.  The fractionation effect on the magnitude of dose discrepancies was 
investigated, as the motion-induced dose deviations were previously shown to “smear 
out” over multiple fractions of IMRT treatments [4,23,24].  It was assumed that each 
treatment fraction commenced at a random phase of tumour motion.  The interest for 
hypofractionation (3 fractions) was prompted by the recent clinical trials on 
hypofractionated stereotactic radiotherapy, which is current being regarded as a 
promising treatment option for lung cancer [25-27]. 
4.2 Materials and Methods 
4.2.1 Multi-Pass Respiratory Gating Technique 
4.2.1.1 Helical Tomotherapy, Tumour Motion, and Gating 
Parameters 
The helical tomotherapy parameters include fan beam thickness (b), pitch factor (p), 
gantry rotation period (Tg), leaf opening time per beam projection (Ta), and number of 
gantry rotations per fraction (R).  At the axis of gantry rotation (i.e. isocenter, SAD = 85 
cm), the fan beam is projected to be 40 cm wide (X) with a selectable fan beam thickness 
(b) of 1.05 cm, 2.5 cm, or 5.0 cm (Y).  Pitch factor (p) is defined as the longitudinal (Y) 
progression distance of the treatment couch per gantry rotation, in units of fan beam 
thickness (b).  Gantry rotation period (Tg) is the time required to complete one full gantry 
rotation, which consists of 51 equally-spaced beam projections.  During the different 
beam projections, each binary leaf remains open for a planned duration (0 < Ta < Tg / 51).  
In the current study, the gantry rotation periods of 15 s and 16 s were used for different 
test cases.  Gantry rotation periods of less than 20 s are typically used clinically for lung 
tomotherapy.  The total treatment time per fraction is thus the product of the gantry 
rotation period (Tg) and the number of gantry rotations per fraction (R).   
The tumour motion parameters consist of amplitude (A) and tumour motion period (Tr).  
Amplitude (A) is defined as one-half of the peak-to-peak amplitude (2A) of tumour 
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motion, while tumour motion period (Tr) is the time elapsed for one full cycle.  In this 
study, the effectiveness of the proposed technique was tested for the superior-inferior 
motion only, as it is the predominant direction of tumour motion [24,28-30].   
The gating parameters are number of passes (n), duty cycle (dc), and gating window size.  
Duty cycle (dc) is a parameter used for phase gating, which is defined as the fraction of 
tumour motion period (Tr) during which radiation is delivered.  Gating window size is a 
parameter for amplitude gating, which is the magnitude of target motion allowed during 
gated radiation delivery.    
4.2.1.2 Leaf Opening Sinogram 
During a helical tomotherapy delivery, intensity modulation is performed by the b-MLC, 
consisting of 64 interlaced binary leaves.  The binary leaves travel along the longitudinal 
direction (+Y) to either move into or out of the different sections of the fan beam.  The 
radiation fluence passing through the different beamlets is determined by the durations of 
leaf openings during each beam projection.  The leaf opening time information is stored 
in the form of a leaf opening sinogram, which is a two-dimensional matrix of relative leaf 
opening time values (T0), with the row and column indices representing leaf number and 
beam projection number, respectively.  The relative leaf opening time is defined as the 
ratio of the actual leaf opening time (Ta) for a beam projection to the maximum leaf 
opening time per beam projection (Tm = Tg / 51).  In this study, a user-created leaf 
opening sinogram was utilized for the non-IMRT cases, while a leaf opening sinogram 
for the IMRT cases was generated via the helical tomotherapy plan optimizer 
(TomoTherapy v. 2.2.2, TomoTherapy Inc., Madison, WI). 
4.2.1.3 General Concept of Multi-Pass Respiratory Gating 
In the multi-pass respiratory gating technique, the gated helical tomotherapy is achieved 
by delivering only the beam projections that occur within a respiratory gating window, 
while blocking the remaining beam projections via the complete closure of all MLC 
leaves.  After each pass, the couch is reset to its starting position, and the treatment 
recommences at a different phase of tumor motion for the previously blocked beam 
projections to coincide with the gating window.  This process is repeated until the entire 
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plan dose is delivered (“full gating”).  However, this approach may not be clinically 
feasible, as the number of passes (n) required may become too high, due to the 
complexities of tumour motion patterns.  Thus, an alternative approach is halting the 
gating process after a certain number of passes, and delivering the entire remaining 
planned dose in a subsequent final pass without gating (“partial gating”).  
In Figure 4.1, the multi-pass respiratory gating method with the full gating approach is 
illustrated for a simple non-IMRT case.  In Figure 4.1 a), the displayed leaf opening 
sinogram (right panel) is designed to treat an off-axis target (left panel).  For illustrative 
purposes, we assume a uniform fluence from all beam projections.  The gating window is 
centered at the end-expiration phase with an unusually high duty cycle (dc) of 50%, 
where the entire leaf opening sinogram is completed over two gated passes (Figure 4.1 b 
and c).  The peak-to-peak amplitude (2A) of target motion in this example was 2.0 cm, 
yielding a residual motion of 1.0 cm within the gating window.    
4.2.1.3.1 Ideal Scenario: Sinusoidal Waveform 
The feasibility of the full gating approach was first tested for sinusoidal motion with a 
constant amplitude (A) and target motion period (Tr), through experimental measurements 
using film (Section 4.2.3) and computer simulation (Section 4.2.4) for a single fraction.  
The test cases included a non-IMRT helical tomotherapy case (Section 4.2.2.1) exhibiting 
the dose rippling and dose rounding effects, and an IMRT helical tomotherapy case 
(Section 4.2.2.2) displaying the IMRT leaf opening asynchronization and dose rounding 
effects.  Phase gating was used with the gating window centered at the end-expiration 
phase for two different duty cycles (dc) of 50% and 25%.  The duty cycle of 25% 
represents the clinical scenario, while the duty cycle of 50% was chosen as the “stress” 
case for the proposed gating method. 
4.2.1.3.2 Realistic Scenario: RPM Waveform 
Both full and partial gating methods were then investigated for a patient respiratory 
motion pattern, through computer simulation (Section 4.2.4) for the IMRT helical 
tomotherapy case (Section 4.2.2.2).  The patient waveform was acquired by the Real-time 
Position Management (RPM) system (Varian Medical Systems, Palo Alto, CA).  In this 
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study, it was assumed that the anterior-posterior motion of the RPM block placed on the 
patient’s abdomen represented the actual tumour motion.  Amplitude gating was 
employed due to the constantly changing amplitudes of the RPM trace, including two 
large erratic peaks that may represent unexpected physiological events such as patient 
coughing.  For different fractionation schemes (1, 3 and 30 fractions), we determined the 
optimal gating parameters to keep the root-mean-square of dose deviations (RMS∆D) 
from the planned dose profile below 1.0%, both inside the PTV and for the entire profile.  
The amplitude gating window size ranged from 4 to 7 mm, in an increment of 1 mm. 
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Figure 4.1: Multi-pass respiratory gating technique with the full gating approach 
(dc = 50%).  (a) Left panel: Off-axis target, Right panel: Leaf opening sinogram.  (b) 
First gated pass.  Only the beam projections occurring within the gating window are 
delivered.  (c) Second gated pass.  The treatment commences at a different starting 
phase of the tumour motion to deliver the previously blocked beam projections. 
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4.2.2 Treatment Planning 
4.2.2.1 Non-IMRT Helical Tomotherapy Plan 
A non-IMRT plan was designed to deliver uniform fluence to the central axis of a 5.5 
cm-long cylindrical target volume, aligned with the axis of gantry rotation.  The target 
volume was located inside the film insert that moves through an opening of the body 
phantom (Modus Medical Devices Inc., London, Canada), shown in Figure 4.2 a).  
Maximum leaf opening time (to = 1) was assigned to the four central leaves with the rest 
of the leaves remaining fully closed (to = 0) for all beam projections over four gantry 
rotations (R = 4).  A fan beam thickness (b) of 2.5 cm was used with a pitch factor (p) of 
0.8 and a gantry rotation period (Tg) of 16 s.  A pitch factor of 0.8 was chosen instead of 
typical pitch factors of less than 0.3 for lung cancer tomotherapy [31], in order to 
intentionally generate dose rippling. 
4.2.2.2 IMRT Helical Tomotherapy Plan 
The IMRT helical tomotherapy plan was generated using the stationary CT images of the 
body phantom (ρ = 1.18 g cm-3, length = 12 cm, width = 30 cm, height = 20 cm).  On the 
CT images of the body phantom (Figure 4.2 b), a virtual C-shaped PTV (length = 6.6 cm) 
was delineated to wrap around a cylindrical OAR (length = 3.6 cm), using a commercial 
treatment planning system (Pinnacle 8.0d, Philips Medical Systems).  The CT images and 
contours were then exported to the tomotherapy treatment planning system 
(TomoTherapy version 2.2.2, TomoTherapy Inc., Madison, WI), where a dose of 2.0 Gy 
was prescribed to 95% of the PTV with the maximum OAR dose being limited to 0.8 Gy.  
A pitch factor (p) of 0.287 (i.e. 0.86 / 3) was selected to minimize the “thread artifact” 
[32] with a fan beam thickness of 2.5 cm.  The optimized dose distribution in a transverse 
plane is shown in Figure 4.2 c).  The leaf opening sinogram generated through the plan 
optimization consisted of 819 beam projections (R ~ 16).   
The plan leaf opening sinogram was then truncated to 408 beam projections (R = 8) by 
eliminating the first 252 and the last 159 beam projections, decreasing the plan dose from 
2.0 Gy to 1.75 Gy.  This was done to shorten the length of the PTV from 6.6 cm to 3.24 
cm, so that the resulting PTV region fell well within the length of the body phantom 
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while in motion.  This was deemed acceptable, as the objective of this study was not to 
reproduce a particular plan, but to investigate how the multi-pass gating technique can 
effectively minimize the dose discrepancies between the gated and planned dose 
distributions. 
 
Figure 4.2: IMRT helical tomotherapy plan for a stationary target.  Dose of 2.0 Gy 
was prescribed to 95% of the PTV with the maximum OAR dose being limited to 0.8 
Gy.  (a) Photograph of the lucite body phantom (ρ = 1.18 g cm-3, length = 12 cm, 
width = 30 cm, height = 20 cm) mimicking a human torso.  The different features of 
the motion phantom are labelled in the “zoomed-in” picture.  (b) Transverse CT 
image of the stationary body phantom with the contours of the PTV (dark), OAR 
(light), and the phantom outline.  The coronal film insert remained stationary inside 
the body phantom at its mid-position during the CT scanning process.  (c) Plan dose 
distribution in the transverse plane.  
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4.2.2.3 Gated Leaf Opening Sinograms 
A series of gated leaf opening sinograms was generated for each plan leaf opening 
sinogram, to experimentally simulate a multi-pass gated delivery.  The plan leaf opening 
sinograms for the non-IMRT and IMRT cases were modified according to the gating 
parameters, using a code written in MATLAB (Mathworks, Natick, MA).  For the 
modification process, the plan leaf opening sinogram must be first transposed, as shown 
in Figure 4.3 a).  Only the beam projections occurring within the gating window are left 
unchanged, while the remaining beam projections are replaced with a relative leaf 
opening time value of ‘0’ to “block” the radiation delivery (Figure 4.3 b).  When more 
than half of a beam projection overlaps with the gating window, the beam projection is 
deemed to be inside the gating window, and vice versa.  Thus, the actual “Beam ON” 
time per tumour motion cycle may be either longer or shorter than the intended duration 
set by the gating window.  For each investigated case in this study, however, the 
cumulative difference over the entire treatment was zero.  For the subsequent passes, the 
beam projections completed during the previous passes are now “blocked” to avoid 
replication, while the previously undelivered beam projections are assigned with their 
original leaf opening time (Figure 4.3 c).  The resulting gated leaf opening sinograms 
were then re-transposed and converted to the tomotherapy file format for deliveries at the 
treatment console. 
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Figure 4.3: Leaf opening sinograms for the full gating method.  (a) “Transposed” 
plan leaf opening sinogram.  The row and column indices now represent projection 
number and leaf number, respectively.  (b) Gated leaf opening sinogram for the first 
pass.  Only the beam projections occurring within the gating window are left 
unchanged, while the remaining beam projections are replaced with a relative leaf 
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opening time value of ‘0’ to “block” the radiation delivery.  (c) Gated leaf opening 
sinogram for the second pass.  The beam projections completed during the first pass 
are “blocked”, while the previously undelivered beam projections are assigned with 
their original leaf opening time. 
4.2.3 Experimental Measurements for a Sinusoidally Moving 
Target 
The experimental measurements were carried out on the helical tomotherapy machine 
(Hi-Art II, TomoTherapy Inc., Madison, WI) to investigate the effectiveness of the multi-
pass gating technique, using a body phantom with a moving film insert (Figure 4.2 a). 
The film insert travelled in a sinusoidal manner with a fixed target motion period (Tr) and 
amplitude (A).   
4.2.3.1 Motion Body Phantom 
The motion phantom (Figure 4.2 a) consists of a lucite body phantom (ρ = 1.18 g cm-3, 
length = 12 cm, width = 30 cm, height = 20 cm) mimicking a human torso, and a 
sinusoidally moving lucite film insert (ρ = 1.18 g cm-3, length = 18 cm, diameter = 8 cm).  
The film insert was positioned to move through the central opening of the body phantom.  
The film (length = 15 cm, width = 6 cm) was placed on the coronal plane centered along 
the axis of gantry rotation, inside the film insert.  The film insert contains five pins at its 
inside corners (2 at one corner, and 1 at each of the three corners) to generate pinprick 
landmarks on each film, which were later used to align a pair of scanned film images for 
direct dosimetric comparisons.  The amplitude of the film insert motion is set by 
adjusting the position of the translation stage holding film insert.  The motion phantom is 
also equipped with a “chest-height” platform, whose vertical up-and-down motion 
represents the anterior-posterior (AP) motion of a “chest wall”, and moves with an 
identical frequency as the film insert.  The period of the film insert motion was verified 
by measuring the positions of the optical markers placed on the platform, using an optical 
tracking camera (NDI, Waterloo, ON) with a sampling frequency of 60 Hz. 
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4.2.3.2 Calibration for Film Dosimetry 
The calibration process was performed at the helical tomotherapy, on the same day of the 
experiment.  A cylindrical solid water phantom (“Cheese” phantom, length = 18 cm, 
diameter = 30 cm, TomoTherapy Inc., Madison, WI) was used.  A 10” x 12” EDR2 film 
was placed on the coronal plane bisecting the “Cheese” phantom, which was centered 
along the isocentre.  The calibration procedure delivered eight 3-cm2 square fields with 
known dose of 30.5 cGy, 65.2 cGy, 100.9 cGy, 128.2 cGy, 159.5 cGy, 188.9 cGy, 215.0 
cGy, and 244.4 cGy.  The calibration film was processed along with a blank film to 
enable background subtraction.  The developed films were scanned with a Vidar VXR-16 
DosimetryPro scanner (Vidar Systems Corporation, Herndon, VA), and analyzed with the 
RIT113 V4 software (Radiation Therapy Dosimetry Software, Colorado Springs, CO).  A 
region of interest (ROI) of 2 cm2 was placed inside each of the eight different fields on 
the calibration film and within the blank film.  The average optical densities (O.D.) of the 
ROIs were then used to generate an O.D. versus dose calibration curve.  
4.2.3.3 Radiation Delivery 
All the film experiments were carried out in the non-clinical “service” mode at the helical 
tomotherapy unit.  For each case, three different delivery scenarios were performed: (1) 
“no motion”, (2) “motion, no gating”, and (3) “motion, gating”.  An electronic 
communication was established between the tomotherapy machine and the motion 
phantom, such that the film insert motion would commence once the gantry angle 
reached zero.  For the “no motion” and “motion, no gating” scenarios, the starting phase 
of the film insert motion was set to zero, by positioning the film insert at its mid-position 
before the start of radiation delivery.  For the “motion, gating” scenario, the film insert 
position was adjusted to commence at a different phase for each pass.   
Ideally, the starting positions of the film insert for Scenario (1) & (2) should correspond 
to the average film insert position inside the gating window for Scenario (3).  However, 
this will require a separate CT scan of the body phantom for each case, with the film 
insert positioned according to the target motion amplitude (A) and gating parameters.  In 
this particular situation, the anatomy of the body phantom does not vary radiologically 
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along the longitudinal direction.  Thus, the stationary (1) and non-gated (2) dose profiles 
can be aligned with the gated dose profiles (3) by simply applying a rigid shift (∆y) along 
the longitudinal direction, which was equal to the average target position inside the gating 
window. 
4.2.3.4 Experimental Data Analysis 
During the experimental data analysis, the dose deviations from the planned dose profile 
were evaluated inside the PTV.  This task was performed to determine the combined 
effects of the different dose discrepancies, and the resulting improvements with the multi-
pass gating technique.  For the non-IMRT helical tomotherapy case, penumbral size and 
dose rippling magnitude were introduced as the metrics to quantify dose rounding and 
dose rippling effects, respectively.  Penumbral size was defined as the average of two 
distances between the 20% and 80% dose points (P20/80), and the 80% and 20% dose 
points (P80/20).  Dose rippling magnitude was measured as the dosimetric difference 
between the highest dose peak and the lowest dose valley inside the PTV.   
The dosimetric uncertainty of the film experiment for the non-IMRT helical tomotherapy 
case (p = 0.8, Tg = 16 s, R = 4) was measured from the five measured “no motion” dose 
profiles.  Standard deviations were calculated for all dose points, once the dose profiles 
were aligned by the center of the PTV regions.  The mean of all standard deviations 
values was then determined to yield a dosimetric uncertainty of +0.5%.  For the IMRT 
helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8), the dosimetric uncertainty of 
+1.0% was calculated from the standard deviation of the maximum PTV dose for the 
three “no motion” film dose distributions. 
4.2.4 Computer Simulation 
A computer program was developed to calculate simulated longitudinal dose profiles 
along the axis of gantry rotation inside a body phantom.  The simulation program 
described in a previous publication [7] was used to generate the longitudinal dose profiles 
for a sinusoidally moving target.  Additional parameters such as the number of passes (n) 
and duty cycle (dc) were added to allow dose calculations for phase gating.  The exposure 
time at each longitudinal position was determined by iteratively calculating the total time 
114 
 
spent simultaneously within the gating window, leaf opening window and the two jaws 
defining fan beam thickness (b).  The fluence profile for each gating case was produced 
by summing up the fluence profiles calculated from the different passes, which was then 
converted to a dose profile through the convolution process using a dose spread kernel.   
The computer program was further modified to accept a RPM trace as a numerical input 
waveform, and to perform dose calculations for amplitude gating.  For amplitude gating, 
partial deliveries of the beam projections were allowed, whereas the beam projections 
were either delivered or blocked entirely for phase gating.  In order to study the 
fractionation effect, a random tumour motion phase was introduced at the start of each 
fraction.  The resulting dose profiles for the individual fractions were then accumulated to 
yield a dose profile for multiple fractions. 
4.3 Results 
4.3.1 Non-IMRT Helical Tomotherapy Case, Sinusoidal Waveform 
In Figure 4.4 a) and b), the non-gated and gated longitudinal dose profiles along the axis 
of gantry rotation are presented for the non-IMRT helical tomotherapy case (p = 0.8, Tg = 
16 s, R = 4).  Without gating, a penumbral size of 22 mm was measured, which 
corresponded to an increase of 6 mm over the penumbral size of the planned dose profile.  
With full gating (dc = 25%, n = 4), the penumbral size decreased by 5 mm to 17 mm, 
which was within 1 mm of the planned penumbral size.  The dose rippling magnitude was 
also reduced from 3 to 0.5% by gating.  In Figure 4.4 a), the dose deviations inside the 
PTV ranged from -10 to 2%, with the mean dose difference of -2%.  The dose deviation 
of -10% was observed near the PTV boundary, due to the dose rounding effect.  The 
maximum dose deviation of 2% was less than the dose rippling magnitude of 3%, due to 
the “dose rippling-like” feature present inside the PTV of the planned dose profile.  This 
dosimetric feature was attributed to the oval shape of the body phantom.  In Figure 4.4 b), 
the dose deviations inside the PTV were reduced to within +1%, with the mean dose 
difference of 0.5%.  In both Figure 4.4 a) and b), the simulated dose profiles agreed with 
the corresponding measured dose profiles within a standard deviation of 0.6% inside the 
PTV.  
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Figure 4.4: Non-IMRT helical tomotherapy case (p = 0.8, Tg = 16 s, R = 4) delivered 
in the presence of sinusoidal target motion (Tr = 8 s, A = 1.5 cm) over a single 
fraction.  (a) Non-gated measured and simulated longitudinal dose profiles along the 
axis of gantry rotation.  (b) Gated measured and simulated longitudinal dose 
profiles along the axis of gantry rotation (dc = 25%, n = 4). 
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4.3.2 IMRT Helical Tomotherapy Case, Sinusoidal Waveform 
In Figure 4.5 a), the measured coronal dose distributions are shown for the IMRT helical 
tomotherapy case (p = 0.287, Tg = 15 s, R = 8) under four different radiation delivery 
conditions.  Significant dose discrepancies were evident in the “motion, no gating” dose 
distribution (ii), due to the IMRT leaf opening asynchronization effect.  In Figure 4.5 b), 
the corresponding longitudinal dose profile along the axis of gantry rotation showed 
significant dose deviations ranging from -29 to 5%, with the mean dose difference of 8%.  
Dose rounding effect was also observed near the PTV boundaries.  The measured and 
simulated dose profiles agreed within a standard deviation of 2.5% inside the PTV.  In 
Figure 4.5 c), the renormalized non-gated dose profiles summed over 30 fractions and 3 
fractions with three different sets of random starting phases of target motion are plotted.  
For the 30 fraction scenario, the dose discrepancies of -29 to 5% observed for the single 
fraction case (Figure 4.5 b) decreased to range from -16 to 1%.  For the 3 fraction case, 
however, it was illustrated that the dose variations were dependent upon the values of 
random starting phases.  The first set of random starting phases yielded dose deviations (-
31 to 9%) larger than the single fraction case, while the second set of random starting 
phases produced dose differences (-18 to -1%) that were close to the 30 fraction scenario.  
On the other hand, the dose discrepancies values for the third set of random starting 
phases (-19 to -10%) fell between the single fraction and 30 fractions cases. 
In Figure 4.5 a), significant reductions of dose discrepancies were observed in the 
“motion, 50% gating” dose distribution (iii), while the planned “no motion” dose 
distribution (i) was nearly restored in the “motion, 25% gating” dose distribution (iv).  In 
Figure 4.5 d), the dose deviations of the measured “50% gating” profile (dc = 50%, n = 2) 
ranged from -5 to 2 %, with the mean dose difference of -2%.  In Figure 4.5 e), the use of 
a lower duty cycle (dc = 25%, n = 4) further decreased the measured dose deviations to 
range from -1 to 3%, with the mean dose difference of 2%.  In Figure 4.5 d) and e), the 
measured and simulated dose profiles agreed with a standard deviation of 1.0% inside the 
PTV. 
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Figure 4.5: IMRT helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8) delivered in 
the presence of sinusoidal target motion (Tr = 8 s, A = 1.5 cm) over a single fraction.  
(a) Measured coronal dose distributions under four different radiation delivery 
conditions: (i) “no motion”, (ii) “motion, no gating”, (iii) “motion, 50% gating”, and 
(iv) “motion, 25% gating”.  The dotted lines (x = 0 cm) represent the axis of gantry 
rotation.  (b) Non-gated measured and simulated longitudinal dose profiles along 
the axis of gantry rotation.  (c) Non-gated simulated longitudinal dose profiles along 
the axis of gantry rotation for 30 fractions and 3 fractions with three different sets 
of random starting phases of target motion.  (d) Gated measured and simulated 
longitudinal dose profiles along the axis of gantry rotation (dc = 50%, n = 2).  (e) 
Gated measured and simulated longitudinal dose profiles along the axis of gantry 
rotation (dc = 25%, n = 4). 
4.3.3 IMRT Helical Tomotherapy Case, RPM Waveform 
In Figure 4.6, the simulated longitudinal dose profiles acquired over 3 fractions are 
plotted.  Without gating, the RMS values of dose deviations (RMS∆D) were 2.42% inside 
the PTV and 1.61% for the entire profile.  For full gating with 6 mm gating window and 4 
passes, the RMS∆D values were 2.50% inside the PTV and 1.31% for the entire profile.  
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Although the full gating approach improved the alignment of the resulting dose profile to 
the planned dose profile, the RMS∆D inside the PTV remained high as only 97.9 % of the 
plan dose was completed over 4 passes.  With the 6 mm gating window, the full gating 
method required a total of 6 passes to keep the RMS∆D values below 1.0%.  For partial 
gating, it was possible to achieve RMS∆D values of less than 1.0%, using 4 passes that 
consisted of 3 gated passes and 1 ungated pass (3 + 1).  The RMS∆D values were 0.67% 
inside the PTV and 0.48% for the entire profile. 
 
Figure 4.6: IMRT helical tomotherapy case (p = 0.287, Tg = 15 s, R = 8) delivered in 
the presence of non-sinusoidal target motion (RPM trace) over 3 fractions with 
random starting phases of target motion.  Simulated longitudinal dose profiles are 
calculated for planned radiation delivery, radiation delivery without gating, full 
gating with 6 mm gating window and 4 passes, and partial gating with 6 mm gating 
window and 3 + 1 passes. 
In Table 4.1, the optimal gating parameters are summarized for both gating approaches 
for three different fractionation schemes.  For a single fraction, 4 mm was the maximum 
residual motion allowed to keep the RMS∆D values below 1.0%.  With the small gating 
window of 4 mm, large numbers of passes were needed for both full (12) and partial 
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gating (7 + 1) methods.  For 3 fractions, the required numbers of passes were reduced 
significantly to 6 passes for full gating and 3 + 1 passes for partial gating, with a 6 mm 
gating window.  For 30 fractions, the numbers of passes used were 5 and 2 + 1, with the 
gating windows of 7 mm and 6 mm for full and partial gating methods, respectively.    
Table 4.1: Optimal gating parameters for different fractionation schemes. 
 
4.4 Discussion 
4.4.1 Treatment Planning 
Treatment planning for the multi-pass gating delivery will require the acquisition of a 
4D-CT data set [33-35].  The CT data set reconstructed at the phase corresponding to the 
gating window must be used for target delineation and plan optimization.  During the CT-
scanning, the anterior-posterior (AP) position of the patient’s abdomen should also be 
monitored with the RPM system.  The correlation between the internal tumour motion 
and the motion of the RPM block must be verified, so that the tumour position can then 
be monitored reliably during the treatment.   
122 
 
4.4.2 Selection of Gating Parameters 
The selection of the gating parameters is based on the trade-off between the accuracy and 
efficiency of the gated dose delivery.  Decreasing the duty cycle or the gating window 
size will reduce the residual tumour motion during radiation delivery, thus potentially 
improving the accuracy of dose delivery.  However, this occurs at the expense of 
increasing the number of passes and the treatment time.  This was the motivation behind 
the proposal of the partial gating approach.  The results presented in Table 4.1 shows that 
the partial gating approach requires fewer passes than the full gating method for all three 
fractionation schemes.  Full gating always needs nearly 100% of the plan dose to be 
delivered, regardless of the fraction number.  For partial gating, the required percents of 
plan dose delivered before the last ungated pass were much smaller than 100%, with the 
delivered percent of the plan dose decreasing with the fraction number.  The percents of 
plan dose completed before the last pass were 95.7% for a single fraction, 92.9% for 3 
fractions, and 82.1% for 30 fractions.   
For a single fraction, large numbers of passes were needed for both gating methods to 
keep the RMS∆D values below 1.0%.  The number of required passes was greatly reduced 
for 3 and 30 fractions, due to dose averaging over multiple fractions.  However, the 
differences in the numbers of passes used between 3 and 30 fractions for both gating 
approaches were only one pass.  This indicated that the multi-pass gating technique may 
be applicable to hypofractionation employed in stereotactic radiotherapy [25-27], 
although further studies will be required to validate its suitability. 
4.4.3 Hardware and Software Requirements for Clinical 
Implementation 
Clinical implementation of the multi-pass gating technique will require the following 
three components: (1) Real-time tumour position monitoring system, (2) Communication 
interface for real-time feedback of tumour position, and (3) Gantry startup 
synchronization.   
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4.4.3.1 Real-Time Tumour Position Monitoring Systems 
Currently, there are different types of indirect and direct tumour monitoring systems 
available.  The RPM system provides advantages in terms of its wide availability, ease of 
use and non-invasiveness.  Like other indirect monitoring techniques, however, the 
system works under the assumption that the correlation established prior to a treatment 
will be maintained throughout the treatment.  This may be especially dangerous for lung 
sites, where establishing stable and reliable correlations were shown to be very difficult 
[36].  Monitoring an additional tumour surrogate such as the lung air flow [37-39] may 
work as an assurance check during the treatment.    
The tumour position may be monitored directly with the use of electromagnetic 
transponders implanted into the tumour volume [40,41].  With the Calypso system 
(Calypso Medical Technologies, Inc., Seattle, WA), the electromagnetic transponders are 
tracked electromagnetically by the localization array panel mounted onto the treatment 
couch.  The relatively compact size of the localization array panel also makes the use of 
the Calypso system feasible for the ring gantry configuration of the tomotherapy 
machine.  However, there are added risks of complications, due to the surgical 
implantation procedure of the transponders. 
4.4.3.2 Communication Interface for Real-Time Feedback 
A communication interface must be established between the real-time tumour monitoring 
system and the tomotherapy b-MLC control centre.  In addition, the software interface 
must be programmed to trigger emergency maneuvers such as full b-MLC closures, 
under unexpected respiratory circumstances such as patient coughing, thereby accounting 
for temporary tumour excursions.  It should be noted that there is a total b-MLC latency 
time of 45 ms, which consists of the leaf response latency time of 30 ms and the leaf 
transit time of 15 ms [20].  Thus, in order to execute the intended leaf motions in a timely 
manner, the tumour position must be anticipated 45 ms in advance.  In the past, various 
algorithms have been described in the literature to account for system latency during the 
tumour tracking dose deliveries [42-47]. 
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4.4.3.3 Gantry Startup Synchronization 
At the start of each gated pass, the start of the tomotherapy treatment must be 
synchronized with a particular phase of tumour motion, so that the previously blocked 
beam projections can potentially occur within the gating window.  One may continue to 
rotate the gantry, until the start of the first undelivered beam projection coincides with the 
start of the gating window.  However, significant time may elapse before the 
synchronization is established, making this “waiting” approach impractical.  
Alternatively, the tomotherapy gantry may be modified to allow for a variable gantry 
speed to be used within its physical limits, only before the start of the radiation delivery.  
The freedom to accelerate or decelerate the gantry will significantly reduce the “wait” 
time required for synchronization.  The “near-future” tumour position calculated by one 
of the aforementioned predictive algorithms may be used to determine the required speed 
changes.  At the start of the treatment, the gantry must resume its planned speed, and 
maintain it throughout the treatment.   
4.4.3.4 Potential Issues and Risks of the Proposed Method 
Successful execution of multi-pass respiratory gated helical tomotherapy strongly 
depends on the accurate monitoring of tumour position.  Incorrect synchronizations 
between the gated beam deliveries and tumour motion can potentially yield worse dose 
discrepancies than the non-gated approach, as the gated beam deliveries will be biased 
towards the wrong tumour positions. 
Similar to the gating techniques implemented for linear accelerators, an accurate and 
efficient gated dose delivery will depend on a consistent correlation between a tumour 
surrogate and the actual tumour position, and a fairly regular and predictable breathing 
pattern.  For gated helical tomotherapy, an additional determining factor becomes the 
accuracy of a predictive algorithm for anticipated tumour position.  This will allow for 
timely execution of b-MLC opening and closure according to the observed breathing 
pattern, as well as effective gantry startup synchronization using gantry speed control. 
For the different indirect tumour monitoring techniques mentioned in Section 4.4.3.1, 
however, numerous opportunities exist for the correlation between a tumour surrogate 
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and the tumour position to change over the course of treatment.  The correlation changes 
can occur between the different fractions, between the gated passes within a single 
fraction, or during an individual gated pass.  Thus, the correlation must be periodically 
confirmed or updated with the observed changes in the tumour motion pattern.  However, 
measuring the internal tumour motion will require the patient to be removed from the 
treatment couch for a 4D-CT acquisition [33-35], unless a CT scanner is placed in the 
treatment room [48,49] to minimize the internal variations between the imaging 
verification and treatment processes.  The use of fluoroscopic tubes [50-54] to monitor 
the tumour position in the treatment room becomes complicated for helical tomotherapy, 
because the ring gantry configuration of the helical tomotherapy machine hinders the 
access of these fluoroscopic tubes. 
Direct monitoring approaches such as the use of the magnetic transponders are thus 
recommended to allow for continuous monitoring of tumour position, at the risk of 
potential surgical complications such as pneumothorax.  Fixation rates of the magnetic 
transponders to lung tissues were initially shown to be low in the canine lung [40], but 
addressed with a modified transponder design with stability features [41].  For patients 
who can not tolerate the surgical implantation of the magnetic transponders, indirect 
tumour monitoring methods may still be employed, as long as patients can maintain 
consistent respiratory patterns.  This makes the patient selection process critical for the 
gated helical tomotherapy treatment.  The patient breathing reproducibility was also 
shown to improve significantly with patient coaching [55-57].  
Appropriate emergency maneuvers are essential for clinical implementation of the 
proposed methods, in order to cope with unexpected situations.  Physiological events 
such as coughing that cause sudden and significant changes in the respiratory motion 
pattern must trigger an interlock, in the form of full leaf closures to halt the radiation 
from reaching the patient.  Treatment will only resume, once the patient regains the 
normal breathing pattern.  Both the partially delivered beam projection and undelivered 
beam projections during this suspended time period will be compensated during the 
subsequent gated passes.  However, frequent interruptions during the treatment will 
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significantly increase the treatment session time, making gated helical tomotherapy 
impractical for a particular group of patients.  
4.5 Conclusion 
In this study, the feasibility of multi-pass respiratory gating technique was investigated 
for both ideal and realistic tumour motion patterns.  For sinusoidal motion, the PTV dose 
deviations of -29 to 5% observed without gating were reduced to range from -1 to 3% for 
a single fraction, using full gating with 4 passes.  For a patient waveform, partial gating 
required fewer passes than full gating for all fractionation schemes.  For a single fraction, 
the maximum allowed residual motion was only 4 mm, thus requiring large numbers of 
passes for both full and partial gating methods.  The number of required passes decreased 
significantly for 3 and 30 fractions, allowing residual motion up to 7 mm.  Overall, the 
multi-pass respiratory gating method was shown to be an effective way to reduce the 
various motion-induced dose discrepancies present in helical tomotherapy.  Its clinical 
implementation will require modest modifications to the current helical tomotherapy 
control system. 
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Chapter 5  
5 Summary and Conclusions 
This chapter summarizes all the major findings of this thesis work, and includes 
discussion related to clinical implications, limitations, and future work. 
5.1 Summary 
In the introductory chapter, it was stated that tumour motion due to breathing presents a 
significant limitation for radiotherapy of lung cancer, and more specifically for helical 
tomotherapy.  The research objectives were addressed in the three subsequent chapters, 
investigating the nature of different motion-induced dose discrepancies for helical 
tomotherapy, developing two new motion management methods to reduce these effects, 
and testing the feasibility of the multi-pass respiratory gating technique, in terms of its 
effectiveness and practicality, through computer simulations and film measurements with 
a motion body phantom.  In this final chapter, all the major findings from these chapters 
are summarized, and discussed in terms of clinical implications, limitations, and required 
future work. 
5.2 Motion-Induced Dose Discrepancies and Beam 
Junctioning Effects 
In the presence of tumour motion, a number of different interactions can arise between 
tumour motion and the three continuously moving subsystems (gantry, couch, and b-
MLC) of a helical tomotherapy unit.  Our research focused on a detailed investigation of 
the resulting dose discrepancies and development of challenging solutions to reduce these 
effects.  In addition, there are inherent dosimetric effects arising from helical dose 
delivery, unrelated to tumour motion.  Beam divergence and the resulting partial beam 
overlaps between different gantry rotations can lead to a “threading” dose pattern being 
produced away from the axis of gantry rotation.  Under special circumstances, beam 
junctioning “beating” effect may also be generated along the axis of gantry rotation.  In 
Table 5.1, the three motion-induced dose discrepancies and two inherent beam 
junctioning effects are summarized, in terms of their causes and related key parameters. 
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5.2.1 Dose Discrepancies in the Presence of Tumour Motion 
In this thesis, motion-induced dose discrepancies for helical tomotherapy were 
categorized into three different types: (1) dose rounding, (2) dose rippling, and (3) IMRT 
leaf opening asynchronization.   
Table 5.1: Summary of different dosimetric effects in the presence and absence of 
tumour motion in helical tomotherapy. 
Section Dosimetric Effect Cause Key Parameters 
5.2.1 Dose Discrepancies in the Presence of Tumour Motion 
5.2.1.1 Dose Rounding Effect Dose blurring due to 
tumour motion 
tumour motion amplitude 
(A), secondary effects due to 
dose rippling (below) 
5.2.1.2 Dose Rippling Effect Interplay between 
couch and tumour 
motion 
gantry rotation period (Tg), 
pitch factor (p), tumour 
motion period (Tr) 
5.2.1.3 IMRT Leaf Opening 
Asynchronization 
Effect 
Interplay between 
IMRT leaf opening 
pattern and tumour 
motion 
dominant frequency of leaf 
opening sinogram (fs), 
tumour motion period (Tr), 
tumour motion phase 
5.2.2 Inherent Dosimetric Effects in the Absence of Tumour Motion 
5.2.2.1 Thread Effect Off-axis helical beam 
junctioning 
pitch factor (p) 
5.2.2.2 Beating Effect On-axis helical beam 
junctioning 
pitch factor (p), number of 
beam projections per gantry 
rotation (n)* 
*Not to be confused with number of gated passes, also represented by ‘n’ in Chapter 4.   
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5.2.1.1 Dose Rounding Effect 
Dose rounding is defined as the dose blurring of a delivered dose distribution relative to 
the planned dose distribution, in the direction of tumour motion, and is especially 
manifested at the edges of a treated volume.  In Figure 2.5 (a), the resulting ‘softer’ dose 
gradient led to the simultaneous under-dosing of the tumour volume near its boundary 
and over-dosing of normal tissues just outside the tumour volume.  In addition, the 
superior-inferior (SI) component of tumour motion, which coincides with the direction of 
couch motion, further widens the “build-up” and “build-down” of dose associated with 
helical tomotherapy dose delivery, as illustrated in Figure 2.5 (b).  In Chapter 2, the 
magnitude of dose rounding effect was characterized by a penumbral width, calculated as 
an average of two distances between the 20% and 80% dose points (P20/80) within the 
“build-up” region and the 80% and 20% (P80/20) dose points within the “build-down” 
region.  Dose rounding effect was shown to be mainly dependent upon tumour motion 
amplitude (A), with other parameters making smaller contributions.  In Figure 2.5 (c), the 
magnitude of dose rounding effect was shown to increase with tumour motion amplitude.  
Small differences of 0.4 to 2.7 mm were observed between the two tumour motion 
periods (Tr) at different tumour motion amplitudes, as the dose rippling effect (Section 
5.2.1.2) present inside the target volume for Tr = 8 s led to the sharpening of the 
penumbral region.  Depending on the phase of tumour motion, the penumbral width can 
also further increase in the presence of dose rippling effect.  Additionally, use of a 
smaller pitch factor may contribute to the widening of the penumbral region.19  
5.2.1.2 Dose Rippling Effect 
Dose rippling is caused by the interplay between the couch motion and periodic tumour 
motion along the direction of couch movement.  The superior-inferior (SI) component of 
tumour motion directly interferes with the irradiation of tumour volume, as its direction 
of motion coincides with the longitudinal movement of the treatment couch.  In the 
                                                 
19
 Dose rounding becomes more sensitive to tumour motion amplitude (A), as the treatment couch slows 
down.  Treatment couch velocity can be reduced by either decreasing the pitch factor (p) or increasing the 
gantry rotation period (Tg). 
134 
 
presence of SI motion, tumour volume is forced to move in and out of the passing 
treatment beam, preventing the planned tumour volume slices from being fully treated in 
a sequential manner, thus leading to non-uniform dose deposition within the tumour 
volume.  In Figure 2.6 (a) and (b), when a sinusoidally moving target volume is irradiated 
with an unmodulated beam (i.e. non-IMRT helical tomotherapy plan), the dose rippling 
effect was shown to be manifested as a series of equally-spaced dose peaks and valleys 
inside the target volume, resembling a wave “interference” ripple.  The successive peaks 
or valleys are separated by the distance travelled by the treatment couch during one cycle 
of tumour motion.  However, uniform dose delivery to the target volume could still be 
achieved for a special condition between the linear couch motion and periodic tumour 
motion.  Under this “dose equilibrium” condition, the excess or deficient dose delivered 
to a particular tumour point, caused by the movement of the leading beam edge in the 
tumour coordinate system, is compensated exactly by the movement of the trailing beam 
edge, as illustrated in Figure 2.3 (a).  In the remainder of this section, a dose equilibrium 
condition for dose rippling effect will be referred to as a synchronous interplay condition.   
In Chapter 2, the dose rippling parameter (β) (defined in Equation 2.6) was introduced as 
a key metric to predict the presence (β ≠ integer) or absence (β = integer) of dose 
rippling effect.  The β-parameter represents the number of tumour motion cycles 
completed while advancing the treatment couch by one fan beam thickness.  The 
relationship between an integer β value and a synchronous interplay condition was 
mathematically derived in the Appendix of Chapter 2.  In Figure 2.6 (c), a common β 
value from different combinations of treatment and tumour motion parameters was 
shown to yield comparable dose modulations, further affirming β as an appropriate 
metric for dose rippling effect.   
The magnitude of dose rippling was defined as the difference between the maximum dose 
peak and the minimum dose valley observed inside the target region, along the axis of 
gantry rotation.  The dose rippling effect was then investigated as functions of tumour 
motion amplitude (A) and dose rippling parameter (β).  In Figure 2.6 (d), the relationship 
between the magnitude of dose rippling and tumour motion amplitude exhibited a 
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complex periodic pattern, with the maximum value decreasing with the tumour motion 
amplitude, perhaps contrary to intuition.  The observed periodicity was attributed to the 
use of pure sinusoidal target motion.  In Figure 2.6 (e), the magnitude of dose modulation 
was plotted against β for different tumour motion amplitudes.  The magnitude of dose 
rippling was shown to decline rapidly with increasing β to less than 1% at β = 4.5 for all 
tumour motion amplitudes.  At each non-integer β value, the relationship between the 
magnitude of dose rippling and tumour motion amplitude was shown to be different, 
while dose rippling was absent at integer β values, as expected.  In Figure 2.7 (a), it was 
shown that dose rippling effect could also be observed for an IMRT helical tomotherapy 
plan.  The phase of tumour motion was shown to affect the positions of the dose peaks 
and valleys, as well as the penumbral width, although the magnitude of dose modulation 
remained unchanged.   
5.2.1.3 IMRT Leaf Opening Asynchronization Effect 
The IMRT leaf opening asynchronization effect arises from the interplay between the b-
MLC motion and periodic tumour motion.  When the dominant frequency of superior-
inferior (SI) tumour motion approaches the dominant frequency (fs) of the plan leaf 
opening sinogram along the direction of couch movement, dose discrepancies unique to 
an IMRT helical tomotherapy plan can be generated, as illustrated in Figure 2.7 (b).  In 
Figure 2.7 (c), the longitudinal dose profile acquired along the axis of gantry rotation 
exhibited dose deviations ranging from -29% to 7% inside the PTV, yielding a root-
mean-square of dose deviations (RMS∆D) equal to 14%.  In Figure 2.7 (d), the IMRT leaf 
opening asynchronization effect was shown to worsen with tumour motion amplitude, 
while its sensitivity to the phase of tumour motion was also demonstrated in Figure 2.7 
(e).  The IMRT leaf opening asynchronization effect was shown to decrease significantly, 
however, in the presence of more complex tumour motion.  When a tumour surrogate 
waveform acquired with the Real-time Position Management (RPM) system (Varian 
Medical Systems, Palo Alto, CA) for a real patient was employed to represent tumour 
motion, dose deviations ranging from -9% to -2% were observed inside the PTV, yielding 
a RMS∆D value of 6%.  The great reduction in dose deviations may be attributed to the 
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absence of dominant tumour motion frequency close to the fs value, as well as the 
presence of multiple frequency components making up the RPM waveform. 
The presence of the IMRT leaf opening asynchronization effect could be anticipated prior 
to a helical tomotherapy treatment by performing a Fourier analysis of the plan leaf 
opening sinogram, as well as the tumour motion pattern to determine their respective 
dominant frequencies.  In Figure 5.1, a frequency spectrum was generated for the 
intensity modulation pattern of a central binary leaf from the plan leaf opening 
sinogram20 generated in Chapter 2 and 4.  The observed dominant frequency (fs) of 0.133 
Hz closely matched the tumour motion frequency of 0.125 Hz (Tr = 8 s) employed in 
Figure 2.7 (c), thus explaining the significant dose discrepancies observed in this figure.  
The IMRT leaf opening asynchronization effect was not generated however, when 
tumour motion frequencies close to the other frequency components of the plan leaf 
opening sinogram were selected, as illustrated in Figure 5.2.  Only dose rounding was 
present for these tumour motion frequencies.  Thus, Fourier analysis may serve as a quick 
quality assurance (QA) check to ensure that no major resonance exists between the IMRT 
leaf opening pattern and tumour motion.  The Fourier analysis may even be performed 
for a newly acquired patient waveform before each treatment fraction to account for the 
inter-fraction variability of tumour motion pattern [1,2] – possibly caused by changes in 
tumour volume and shape, as well as patient’s respiratory capacity over the course of 
radiotherapy treatment. 
                                                 
20
 This plan leaf opening sinogram refers to the truncated version of the plan leaf opening sinogram 
generated in Figure 2.1 and 4.2.  Truncation process is explained in both Section 2.2.1.4 and 4.2.2.2. 
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Figure 5.1: Frequency spectrum for the intensity modulation pattern of a central 
binary leaf.  Its dominant frequency (fs) was observed at 0.133 Hz. 
 
Figure 5.2: Simulated longitudinal dose profiles along the axis of gantry rotation for 
the IMRT helical tomotherapy plan (p = 0.287, Tg = 15 s, R = 8) generated for 
different tumour motion periods (Tr) with a tumour motion amplitude (A) of 1.5 cm.  
The IMRT leaf opening asynchronization effect was observed only for Tr = 8 s. 
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5.2.2 Dosimetric Effects in the Absence of Tumour Motion 
The two inherent beam junctioning effects for helical tomotherapy, unrelated to tumour 
motion are the (1) thread effect, and (2) beating effect.  These effects are not classified as 
dose discrepancies (i.e. dose differences between the planned and delivered dose 
distributions), because they are clinically accounted for during the dose calculations of 
the treatment planning system.  In this work, they have been observed experimentally, as 
other investigators have [3], and hence are only discussed here briefly.  
5.2.2.1 Thread Effect 
The thread effect is a well known off-axis helical beam junctioning effect, inherent to 
helical tomotherapy [3].  Even with perfect beam overlaps along the axis of gantry 
rotation for a uniform dose delivery, the thread effect can still be generated away from 
the axis of gantry rotation, due to beam divergence.  As the projected fan beam thickness 
changes according to the distance from the x-ray source, alternating beam overlap and 
gaps are created off-axes.  The resulting dose peaks and valleys both follow a helical 
trajectory, resembling a screw thread.  Fluence also changes according to an inverse-
square of distance from an x-ray source; attenuation and scatter are other contributing 
factors for the thread effect [3].  The successive dose peaks and valleys along off-axes are 
separated by a distance equal to the couch translation during each gantry rotation (i.e. 
pitch factor (p) * fan beam thickness (b)), as illustrated in Figure 3.4.  Dose difference 
between dose peaks and valleys was shown to increase with off-axis position, as expected 
with greater divergence distance, according to the results from Table 3.3. 
5.2.2.2 Beating Effect 
The beating effect is an on-axis beam junctioning effect generated only under highly 
specific treatment conditions.  In Chapter 3, n / p ratio was used as a metric for predicting 
the presence (n / p = non-integer) and absence (n / p = integer) of the beating effect, as 
indicated by the results summarized in Table 3.3, where n is the number of beam 
projections per gantry rotation and p is the pitch factor.  The n / p ratio represents the 
number of beam projections delivered (Nb), after the treatment couch moves a distance 
equal to one fan beam thickness: 
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With a non-integer n / p ratio, the total number of beam projections encountered by 
different parts of a target volume alternates between two values, leading to the periodic 
dose peaks and valleys along the direction of couch  motion, observed in Figure 3.11.  
The magnitude of beating effect was shown to decrease with an increasing n / p ratio, as 
the relative dosimetric contribution of the extra beam projection decreases with an 
increasing number of beam projections.  The decreasing separation distance between dose 
peaks with increasing n / p ratio, further contributes to the dose peak reduction.  The 
separation distance between the successive dose peaks or valleys is equal to the couch 
increment per beam projection (i.e. projection increment defined in Equation 3.3).   
The work in Chapter 3 was done before the arrival of the Hi-Art II helical tomotherapy 
machine (TomoTherapy Inc., Madison, WI) at the London Regional Cancer Program 
(LRCP) in May of 2004.  Helical tomotherapy dose delivery was experimentally 
simulated using a linear accelerator x-ray beam by delivering a series of static beams 
from different gantry angles and couch positions.  The results in Chapter 3 could be 
replicated with the current helical tomotherapy unit by assigning a very short leaf 
opening time per beam projection, mimicking a static beam projection, and a pitch factor 
larger than 7 to keep the n / p value below 7.5.  However, the magnitude of dose peaks 
may still be reduced slightly, due to the presence of continuous couch motion. 
5.3 Clinical Implications 
In this section, the clinical implications for each of the motion-induced dose 
discrepancies produced in the presence of tumour motion, and the two beam junctioning 
effects inherent to helical tomotherapy dose delivery will be discussed. 
5.3.1 Presence of Tumour Motion 
Dose rounding is a clinically-relevant effect that worsens with tumour motion amplitude, 
as shown in Figure 2.5 (c).  The reduced tumour dose delivered near the tumour boundary 
can be compensated by increasing the treatment margin according to the magnitude of 
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dose rounding.  For large amplitudes of tumour motion, however, the resulting margin 
expansion would significantly increase the total irradiated volume of surrounding normal 
tissues, potentially increasing radiation toxicity and necessitating the use of a motion 
management technique.  It is highly unlikely that the dose rippling effect would yield 
significant impact in clinical practice, where pitch factors of less than 0.3 are typically 
used with gantry rotation periods of 15-20 seconds.  Use of such treatment parameters 
would likely yield β values much greater than 4.5, where the magnitude of dose rippling 
was shown to become negligible in Figure 2.6 (e) – unless unusually long tumour motion 
periods are exhibited by the patients.  The IMRT leaf opening asynchronization effect 
could introduce significant dose discrepancies within the tumour volume, as illustrated in 
Figure 2.7 (b) and (c).  For a conventional fractionation scheme, however, the dose 
deviations resulting from the IMRT leaf opening asynchronization effect may “wash out” 
over multiple fractions.  In Figure 2.7 (e) and Figure 5.3, the simulated dose profiles 
accumulated over 30 fractions exhibited only dose rounding in the presence of sinusoidal 
and non-sinusoidal target motion, respectively.  A randomly selected tumour motion 
phase was assigned at the start of each fraction for calculation of these cumulative dose 
profiles.  On the other hand, the IMRT leaf opening asynchronization may still have a 
clinical impact, when hypofractionation schemes are employed.  In Figure 4.6, the 
simulated dose profile accumulated over 3 fractions without gating for non-sinusoidal 
target motion, exhibited both IMRT leaf opening and dose rounding effects, yielding an 
RMS∆D of 2.4% within the PTV.  Thus, for clinical practice, the use of a motion 
management technique may become necessary during helical tomotherapy treatments, 
especially for patients displaying large amplitudes of tumour motion being treated with 
hypofractionation schemes. 
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Figure 5.3: Simulated longitudinal dose profiles along the axis of gantry rotation for 
the IMRT helical tomotherapy plan (p = 0.287, Tg = 15 s, R = 8) accumulated over 30 
fractions in the presence of a non-sinusoidal target motion (RPM trace).  A 
randomly selected tumour motion phase was assigned at the start of each fraction. 
5.3.2 Absence of Tumour Motion 
It is highly unlikely that the beating effect will be clinically relevant for helical 
tomotherapy.  With the number of beam projections per gantry rotation fixed at 51 and 
pitch factors of less than 0.3 typically used clinically, the n / p ratio would become 
extremely high and well above the value of 7.5, where a maximum dose modulation of 
approximately 5% was observed, according to the results in Table 3.3.  The thread effect 
is accounted for during the treatment planning process.  The current clinical practice at 
LRCP follows the finding by Kissick et al [3], which has shown that thread effect can be 
minimized by using a pitch factor that satisfies the following condition: 
 Ia
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5.4 Tumour Motion Management Techniques 
In this section, the feasibility of employing respiratory gating and breath-holding for 
helical tomotherapy will be discussed, in terms of their effectiveness to reduce the 
magnitude of each individual motion-induced dose discrepancy.  
5.4.1 Multi-Pass Respiratory Gating Technique 
In Chapter 2, dose rounding and the IMRT leaf opening asynchronization effect were 
both shown to worsen with tumour motion amplitude (A).  In addition, target motion 
period (Tr) was shown to be the determining parameter for yielding interplay conditions 
that can generate dose rippling or the IMRT leaf opening asynchronization effect.  When 
multi-pass respiratory gating is employed, the magnitude of tumour travel during beam 
delivery becomes restricted to the residual motion within the gating window.  
Additionally, delivering the treatment beam only during a pre-determined portion of the 
tumour motion cycle introduces an effective “beam ON” tumour motion period that is 
different from the actual tumour motion period (Tr).  In Figure 5.4, it is illustrated that the 
effective tumour motion period (Tr eff) “seen” by the treatment beam during a multi-pass 
gated treatment is calculated as the product of duty cycle (dc) and tumour motion period 
(Tr).  Duty cycle (dc) is defined as the fraction of tumour motion cycle during which the 
radiation delivery is made.  Thus, the multi-pass respiratory gating technique has the 
potential to address all three types of dose discrepancies by effectively reducing the 
magnitude and period of tumour motion during radiation delivery.  The emergence of the 
Tr eff parameter also means the original definition of the dose rippling parameter (β) in 
Equation 2.6 needs to be modified to accommodate for both gated and non-gated 
situations, yielding a newly defined dose rippling parameter, namely the effective dose 
rippling parameter (βeff): 
 
( ) eff
eff 01.001.001.0
1
01.0
1
r
g
r
g
r
g
Tp
T
Tdcp
T
Tp
T
dcdc ⋅
=
⋅
=





⋅
=





= ββ   (5.3) 
In Figure 4.4 (b), the multi-pass respiratory gating technique was shown to effectively 
reduce both dose rippling and dose rounding observed in Figure 4.4 (a).  In Figure 4.4 (a), 
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the two effects combined to yield an RMS∆D of 4% inside the PTV, with a dose rippling 
magnitude of 3%.  In Figure 4.5 (b), the RMS∆D inside the PTV was reduced to 0.7%, 
while decreasing the dose rippling magnitude to 0.5%.  The significant reduction in dose 
rippling magnitude was attributed to establishing a synchronous interplay condition by 
using a duty cycle of 25%, which changed the βeff value from 2.5 to 10.  In Figure 4.5 (b), 
the presence of the IMRT leaf opening asynchronization effect and dose rounding 
produced dose deviations ranging from -29% to 5% inside the PTV, with an RMS∆D of 
14%.  In Figure 4.5 (d), 2 gated passes were employed with a duty cycle of 50% to 
significantly reduce the RMS∆D to 2.4%, with the dose deviations varying from -5% to 
2%.  In Figure 4.5 (e), employing 4 gated passes with a duty cycle of 25% further 
decreased the RMS∆D to 2%, with the dose deviations ranging from -1.5% to 3.5%. 
The practicality of the multi-pass respiratory gating technique was then investigated for 
more complex non-sinusoidal target motion, represented by a patient RPM waveform 
(Table 4.1).  For a conventional fractionation scheme consisting of 30 fractions, the 
number of required passes was shown to range from 3 to 5 to keep the RMS∆D inside the 
PTV below 1%.  For 3 fractions, the number of required passes was shown to increase by 
only a single pass over the 30-fraction scheme.  Thus, the treatment session time required 
for a multi-pass respiratory gated helical tomotherapy treatment may remain comparable 
between different fractionation schemes.  Currently, at London Regional Cancer Program 
(LRCP), each helical tomotherapy treatment is assigned with a treatment session time of 
30 minutes.  The first half of the treatment session is dedicated to patient set-up, MVCT 
acquisition for patient position verification, and patient repositioning, while the second 
half consists of 5-10 minutes of “beam-ON” time and the time needed for the patient to 
leave the treatment room.  The use of 4 to 5 gated passes would yield a “beam-ON” time 
of 20-50 minutes, and with the couch reset time totaling up to 5 minutes, the treatment 
session time may last up to 75 minutes – representing an increase by a factor of 2.5. 
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Figure 5.4: Position vs. time curves of the leading and trailing beam edges in the 
tumour coordinate system for a multi-pass respiratory gated helical tomotherapy 
treatment (p = 0.8, Tg = 16 s, R = 8), employing phase gating (dc = 50%, n = 2).  The 
gating window is centered around the end-expiration phase.  The effective tumour 
motion period (Tr eff) “seen” by the treatment beam is calculated as the product of 
duty cycle (dc) and tumour motion period (Tr). 
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5.4.2 Loose Helical Tomotherapy with Breath-Holding 
With the breath-holding strategy, the dose rounding effect is expected to be minimized to 
a negligible level, as the magnitude of tumour motion approaches zero during breath-
holding.  The residual motion during breath-holds will vary between patients, according 
to their abilities to tolerate and perform breath-holding in a reproducible manner.  In 
addition, minimal tumour motion during radiation delivery would likely yield negligible 
interplay effects, leading to the absence of dose rippling and IMRT leaf opening 
asynchronization effect.   
5.4.3 Thread Effect 
Although the impact of different motion-induced dose discrepancies could be minimized 
by employing a motion management technique, dosimetric effects previously present in 
the absence of tumour motion may resurface.  In Figure 5.5, thread effect observed in the 
planned “no motion” distribution (i) becomes blurred by the presence of tumour motion 
in the “motion” dose distribution (ii).   Interestingly, the thread effect starts to reappear in 
the “gated” dose distribution acquired with a duty cycle of 50% (iii).  The threading 
pattern then becomes clearly visible in the “gated” dose distribution obtained with a duty 
cycle of 25% (iv), as the magnitude of target motion during radiation delivery is further 
reduced.  The dose distributions in Figure 5.5 were generated using four fully-open 
central b-MLC leaves (i.e. non-IMRT helical tomotherapy plan) with the helical 
tomotherapy treatment parameters of p = 0.8, Tg = 16 s, and tumour motion parameters of 
Tr = 8 s, A = 1.0 cm, yielding β = 2.5.   
For loose helical tomotherapy with breath-holding, the thread effect is expected to be 
absent due to the use of multiple “interlaced” helices.  Interlaced helices are generated by 
assigning different gantry start angles (i.e. phases) to the individual helices.  As the 
different helices are out-of-phase from one another, the off-axes dose modulations 
produced by the individual helices are averaged out.  In Figure 3.4 (b) and (d), employing 
four “interlaced” helices 900 out-of-phase from one another was shown to eliminate the 
thread effect observed in the original dose distributions in Figure 3.4 (a) and (c), acquired 
by using a conventional tight helix.  The work by Kissick et al [3] has also demonstrated 
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significant reduction of the thread effect by using double helices that were 1800 out-of-
phase from each other. 
 
Figure 5.5: Central coronal dose distributions produced by a non-IMRT helical 
tomotherapy plan (p = 0.8, Tg = 16 s, R = 4): (i) “no motion” dose distribution, (ii) 
“motion” dose distribution (Tr = 8 s, A = 1.0 cm), (iii) “gated” dose distribution (dc = 
50%, 2 passes), (iv) “gated” dose distribution (dc = 25%, 4 passes).  The tread effect 
previously observed in the “no motion” dose distribution (i) resurfaces in the 
“gated” dose distributions ((iii) and (iv)). 
5.5  Limitations and Future Work 
In this section, limitations of the two proposed motion management techniques, namely 
loose helical tomotherapy with breath-holding and multi-pass respiratory gating 
techniques will be discussed, including recommendations to the manufacturer of the 
helical tomotherapy unit.  In addition, limitations of the work done in this thesis will be 
described, as well as the required future work to address these limitations. 
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5.5.1 Limitations of Proposed Methods 
Both loose helical tomotherapy with breath-holding and multi-pass respiratory gating 
techniques require much longer treatment session time because of the use of multiple 
passes.  In addition, patient position uncertainty could also be introduced, as the treatment 
couch is retracted back to its starting position between passes and patient discomfort may 
ensue.  Fortunately, the helical tomotherapy machine provides the on-board MVCT 
imaging capability to verify patient position and minimize corresponding positional 
uncertainty between passes, at the expense of further increasing the treatment session 
time and dose received by patients.   
There are other patient-related factors.  Patient compliance for breath-holding remains a 
significant issue for loose helical tomotherapy.  Although breath-holding at either normal 
inspiration or expiration could yield higher patient compliance than the 40% rate reported 
for deep-inspiration breath-holding by Memorial Sloan-Kettering Cancer Center 
(MSKCC) [4], nevertheless the proposed breath-holding technique for helical 
tomotherapy is not applicable for all patients.  The use of active breathing control device 
may improve the patient compliance rate [5-7].  Effectiveness of the multi-pass 
respiratory gating technique also requires the patient to maintain a fairly regular tumour 
motion, in terms of tumour motion period, amplitude, and baseline position.  This way, 
the undelivered beam projections from each gated pass can coincide with the gating 
window more easily.  With extremely irregular tumour motion patterns, completing all 
planned beam projections under a reasonable number of gated passes will become very 
difficult, making the patient selection process crucial.  For practical purposes, the partial 
gating approach described in Chapter 4 should be strongly considered over the full gating 
method.  For partial gating, once a certain percentage of beam projections are delivered, 
all remaining beam projections are delivered without gating, thus keeping the total 
number of passes used under a reasonable limit.  In Table 4.1, it was shown that partial 
gating required 8 passes to achieve an RMS∆D of less than 1% for a single fraction, 
compared to 12 passes for full gating.  For 3 and 30 fractions, the partial gating approach 
needed 2 less passes than full gating, requiring 4 and 3 passes, respectively. 
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5.5.2 Recommendations to the Manufacturer 
For clinical implementation of loose helical tomotherapy, modifications to the current 
treatment planning platform must be made by the manufacturer to provide the treatment 
planning capability for multiple helices with large pitch factors.  However, concerns 
remain as conformality of dose distribution to tumour volume may be greatly 
compromised from the use of extremely large pitch factors.  Thus, an extensive treatment 
planning exercise must be performed with large pitch factors to determine its clinical 
feasibility, in terms of dose delivery accuracy and number of loose helices required to 
satisfy different clinical criteria. 
Clinical implementation of respiratory gating for helical tomotherapy would require an 
electronic communication to be established between the tumour monitoring system and 
the b-MLC control center.  An automatic emergency maneuver in the form of full b-MLC 
closure would also be required, in the event that the tumour motion pattern undergoes an 
unexpected change, triggered by a physiological event such as coughing.  As most 
patients would exhibit some degree of irregularity in their tumour motion patterns, it is 
recommended for the manufacturer to provide variable speed capability for both the 
gantry and the treatment couch.  Having these additional degrees of freedom would make 
it easier for the undelivered beam projections to be placed within the gating window 
during subsequent passes. 
5.5.3 Limitations of Current Work and Future Work 
A major limitation of the computer simulation model used in this thesis was that the 
calculation of each dose profile was restricted to the axis of gantry rotation.  A capability 
to generate dose profiles along off-axes would enable one to investigate the 3D impact of 
tumour motion on helical tomotherapy dose delivery.  Different factors such as beam 
divergence and fluence change according to an inverse-square of distance from the x-ray 
source should be accounted for during the calculations of off-axes dose profiles.  For 
experimental measurements, a gel dosimeter [8-10] may be used instead of film to 
acquire 3D dose distributions.   
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The dosimetric impact of more complex non-sinusoidal tumour motion should be 
investigated experimentally.  The motion body phantom used in this thesis was only 
capable of producing sinusoidal motion in one direction, with adjustable tumour motion 
amplitude (A) and period (Tr).  The most recent version of the Modus respiratory motion 
phantom is equipped with a programmable motor capable of replicating different patient-
related motion waveforms (Modus Medical Devices Inc., London, ON), such as the RPM 
waveform used for computer simulation results in Table 4.1.  The dosimetric impact of 
tumour motion components along different directions should also be investigated 
individually or in combination.  Motion along the anterior-posterior (AP) direction would 
affect the fluence reaching the target volume, while motion along the lateral the left-right 
(LR) direction would directly interfere with the b-MLC motion, as it runs perpendicular 
to the movement of each leaf.  In a simplified setup, 1D target motion could be made to 
yield 3D motion components by rotating and tilting the entire motion body phantom 
assembly used in Chapter 2 and 4.  A commercially available dynamic thorax phantom 
(CIRS, Norfolk, VA) provides 3D target motion by simultaneously applying translational 
and rotational motions to a cylindrical insert made of lung equivalent material, containing 
a spherical target volume.   
Lung deformation has been modelled by utilizing deformable lung-equivalent material 
surrounding a target volume, such as sponge [11,12], as well as employing a balloon 
connected to a piston to mimic a human diaphragm [12].  Finally, a non-spherical target 
volume with a more realistic tumour shape has been produced using flexible resin [13].  
The effect of lung deformation on the resulting dose distributions can also be investigated, 
using a deformable gel dosimeter currently being developed at the London Regional 
Cancer Program (LRCP).  A deformable gel dosimeter is created by producing gel inside 
a latex balloon.  Dose calculations on 4D-CT datasets at different phases can also be 
performed to investigate the effect of lung deformation on the resulting dose distributions, 
one phase at a time.  Robust optimization approach [14] may be used to account for 
anticipated motion-induced dose discrepancies in advance during the plan optimization 
process, in addition to other types of uncertainties.  The current approach by Heath et al, 
however, does not account for the interplay between the MLC motion and tumour motion, 
while providing dose rounding reduction, thus requiring further improvements. 
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5.6 Conclusions 
In this thesis, we have isolated three distinctively different types of motion-induced dose 
discrepancies for helical tomotherapy, namely dose rounding, dose rippling, and the 
IMRT leaf opening asynchronization effect.  Each effect was shown to exhibit unique 
characteristics, in relations to the different tumour motion and helical tomotherapy 
treatment parameters.  The major dose discrepancies to be considered in clinical practice 
are dose rounding and the IMRT leaf opening asynchronization effect.  For a 
conventional fractionation scheme, the dose rounding effect remains the major concern, 
which can be compensated by assigning a larger treatment margin around the tumour 
volume.  For hypofractionation schemes, the IMRT leaf opening asynchronization effect 
can become an additional concern by introducing dose discrepancies within the tumour 
volume, necessitating the use of a motion management technique.   
Two new motion management methods have thus been developed for helical 
tomotherapy, in the form of loose helical tomotherapy with breath-holding and multi-pass 
respiratory gating.  The feasibility of the multi-pass respiratory gating technique was 
demonstrated in terms of its effectiveness and practicality, through computer simulations 
and film measurements performed in a motion body phantom.  For sinusoidal target 
motion, the proposed method was shown to reduce the RMS∆D inside the PTV from 14% 
to 2.7% and 2% for respective duty cycles of 50% and 25% requiring 2 and 4 gated 
passes.  For more realistic non-sinusoidal tumour motion causing an RMS∆D of within the 
PTV, the required numbers of passes to keep the RMS∆D below 1% were shown to range 
from 3-5 passes for 30 fractions, and 4-6 passes for 3 fractions, demonstrating the 
feasibility of the multi-pass respiratory gating approach.  In conclusion, employing multi-
pass respiratory gating during helical tomotherapy was shown to greatly reduce the 
different types of dose discrepancies, and decrease the required margin size, potentially 
reducing radiation toxicity and allowing dose escalation for better tumour control.  
Clinical implementation of the multi-pass respiratory gating technique would require a 
number of electronic control and communication modifications to the existing helical 
tomotherapy machine, which would lead to significant improvements in the dose 
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distributions delivered for lung tomotherapy treatments – especially for patients 
exhibiting large tumour motion who are treated with hypofractionation schemes. 
Unique breathing patterns exhibited by each patient warrant a patient-specific approach 
during the treatment planning and dose delivery processes of a helical tomotherapy 
treatment.  The fundamental understanding of the different motion-induced dose 
discrepancies acquired in this thesis work will greatly help with the patient selection 
process to extract maximum clinical benefit with or without the use of a motion 
management technique.  The knowledge gained in this work on different interplay effects 
can also be applied to other treatment modalities, including traditional cone beam 
radiotherapy techniques, as well as more specialized techniques such as stereotactic body 
radiotherapy employing hypofractionation.  Thus, it is hoped that the results of this thesis 
will help improve the clinical outcomes for radiotherapy of lung cancer – a disease that 
continues to remain a challenge for conventional treatment techniques. 
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Appendices 
Appendix A: Supplementary Material for Chapter 2 
Mathematical condition (β = integer) for a synchronous interplay between the couch 
motion and the longitudinal target motion for a non-IMRT helical tomotherapy 
delivery 
In the tumour coordinate system (Figure 2.2 b), the longitudinal boundaries of the fan 
beam H (y) can be defined by the two Heaviside step functions, HT (y) and HL (y) along 
the axis of gantry rotation.  HT (y) and HL (y) represent the trailing and leading beam 
edges respectively, whose positions are determined by the functions, yT (t) and yL (t).  In 
the tumour coordinate system, the fan beam position changes with respect to the 
stationary target volume: 
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 where HT (y) and HL (y) represent the trailing and leading beam edges, respectively, 
and yT (t) and yL (t) are the positions of the trailing and leading beam edges as 
functions of time in the tumour coordinate system, defined as following: 
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 where p is the pitch factor, b is the fan beam thickness, Tg is the gantry rotation 
period, D is the total couch travel during the treatment, R is the number of gantry 
rotations competed during the treatment, Tr is the period of tumour motion, and A is 
the one-half of the peak-to-peak amplitude (2A) of tumour motion along the 
longitudinal direction (+y). 
Each longitudinal point y is irradiated at a given time t, while the point is located between 
the fan beam edges.  The radiation exposure time (∆t) is calculated for each point by 
integrating the fan beam function H (y) over the treatment time (0 < t < R * Tg): 
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The fluence (Φ) received by each point is then determined by multiplying the radiation 
exposure time (∆t) by the fluence rate (φ).  The fluence rate is assumed to be constant in 
this study: 
 ( ) ( ) constant, =∆⋅=Φ φφ yty  (5) 
In the absence of tumour motion, Tg / p is the time required for the couch to travel a 
distance equal to one fan beam thickness (b).  This means the trailing beam edge position 
reaches its corresponding leading beam edge position after the elapsed time of Tg / p: 
 
( ) ( )pTtyty giTiL +=  (6) 
In the presence of tumour motion, the above Condition (6) is reproduced under a 
synchronous interplay condition (β = integer) as Condition (7), shown as the following:  
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Going back to Equation (5) and substituting Equation (4) into (5), 
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Substituting Condition (7), 
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Therefore, under a synchronous interplay condition (β = integer), the fluence inside the 
target region remains constant, thus leading to the absence of dose rippling. 
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